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Abstract
Identification of the Functions of the Carboxy Terminus of AFAP-110 in
Regulating AFAP-110’s Self-association, Cell Localization and the Integrity
of Actin Filaments
Yong Qian
The actin filament associated protein of 110 kDa (AFAP-110) is a SH2/SH3
binding partner for Src.  It has two SH2 binding motifs, one SH3 binding motif, one
proline rich motif, two PH domains and one serine/threonine substrate region at its amino
terminus and has been hypothesized to function as an adapter protein that mediate the
effects of different signal proteins upon actin filaments.  In this report, we demonstrated:
1) AFAP-110 has the ability to self-associate through carboxy terminal interactions.
Analysis of the carboxy terminus of AFAP-110 reveals a leucine zipper motif.
Expression of carboxy terminus as a fusion protein (GST-cterm) can affinity absorb
AFAP-110 from cell lysates, and the integrity of leucine zipper motif in GST-cterm is
required for the affinity absorption.  FPLC confirm AFAP-110 exists in multimeric forms
from monomer to tetramer in vivo; 2) Src527F transformation changes the profile of
AFAP-110’s self-association in vivo and abrogates the affinity absorption of AFAP-110
by GST-cterm in vitro, which is independent of tyrosine phosphorylation; 3)AFAP-110
directly binds to actin filaments through its carboxy terminus.  Analysis of the carboxy
terminus of AFAP-110 reveals that there are two homologies with consensus actin
binding domains (ABD-1 and ABD-3) between amino acids 593-637. 4) AFAP-110 has
an intrinsic ability to modulate the integrity of actin filaments and to induce the formation
of lamellipodia and changes in cell shape, which may be regulated by the leucine zipper
motif.   Taken together, these results indicate that AFAP-110 may position itself upon
actin filaments through the carboxy terminal region, and the leucine zipper motif may
play a regulatory role in affecting the actin filament integrity and the formation of
lamellipodia in response to different cellular signals that include Src.
In addition, we mapped two monoclonal antibody reactive epitopes within AFAP-
110. Mab 4C3 recognized an epitope within the SH3 binding motif of avian AFAP-110
and did not efficiently react with mammalian homologoes of AFAP-110.  Mab anti-
AFAP-110 recognized an epitope within the carboxy terminus of AFAP-110, which is
conserved across the species.  These two monoclonal antibodies provided useful tools to
study AFAP-110.
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1CHAPTER 1
Introduction and Review of Literature
2I. Introduction
Actin filaments
Actin is one of the most abundant protein in eucaryotic cells.  Each actin
monomer (G-actin) has 375 amino acids and has a tightly bound ATP.  The actin
monomers are polymerized to form actin filaments (F-actin), and the polymerization of
actin is associated with hydrolyzing ATP to ADP.  Actin filaments form a polar structure
and its plus (barbed) end is the fast growing end while its minus (pointed) end grows or
elongates much slower.  The basic structure of actin filaments is identical, and it is the
actin binding proteins that create the diverse forms of actin filaments in eucaryotic cells.
There are two major forms of actin filaments, in vivo: stable and labile actin filaments.
The stable actin filaments form the core of microvilli, the contractile apparatus of muscle
cells and main structural components for cell shape while the labile actin filaments are
involving in many cell processes especially cell movement. (Albert et al, 1994).
In vivo, actin filaments are tightly regulated by actin binding proteins.  They are
under continuous cycles of polymerization and depolymerization, and undergo constant
changes in cellular localization and organizations.  They are involved in a wide variety of
cellular processes, including the cell motility, cell shape changes during mitosis, cell
contractile activities, cell-cell/cell-substrate interaction, mRNA localization, cell signal
transduction and endocytosis (Schmidt and Hall, 1998).   Information has emerged
tremendously that there are a lot of clinical diseases that are directly related to the
abnormalities of either expression or localization of actin filaments and actin binding
3proteins (Janmey and Chaponnier, 1995), especially in cardiomyopathies, the
abnormalities of actin filaments and actin binding proteins have been identified to be the
main cause for the diseases (Towbin, 1998).
Rho-GTPase in the regulation of actin filaments
Actin filaments function in the different cell processes through constant
rearrangement and remodeling.  The rearranged actin filaments form several discrete
structures at the cell periphery for attachment to the substratum in response to
extracellular signals.   These discrete structures are focal adhesions, stress fibers,
lamellipodia, filopodia and membrane ruffles (Hall, 1998; Thomas and Brugge, 1997).
The formation of these structures can be regulated by Rho-like GTPases (Hall , 1994).
Rho-like GTPases are the main regulatory proteins to link both extracellular and
intracellualr signals to actin filaments (Schmidt and Hall, 1998). They can be divided into
five groups in eucaryotic cells.  All of them function as binary switches: GTP-Rho-like
GTPases active form and GDP-Rho-like GTPases inactive form.  The main Rho-like
GTPase proteins that are involved in regulating actin filaments are Rho, Rac and CDC42
(Schmidt and Hall, 1998).
Rho regulates the formation of stress fiber and focal adhesion upon growth factor
induction (Ridney and Hall, 1992). The stress fibers are the bundles of actin filaments
associated with myosin and some other actin binding proteins.  One of the main functions
of stress fibers is contractility.  The accumulation of stress fibers upon Rho stimulation is
essential in small muscle cell contraction (Hirata et al, 1992).  The focal adhesion is a
structure by which cells attach to the extracellular matrix and is rich in stress fibers,
4intergrin and some actin binding proteins.  Its’ main function is to provide cells with
adhesive points to extracellular matrix, as the name implies, and also to mediate cell
signal transduction, migration and apoptosis (Taylor et al, 1998).  Rho also has the ability
to stimulate the polymerization of F-actin from new nucleation sites at the cell periphery,
indicating Rho could have the ability to induce the formation of lamellipodia as well
(Adam et al, 1996).
Rac is the second main Rho-like GTPase protein that regulates actin filaments.
Rac is involved in regulating the formation of lamellipodia and membrane ruffles through
stimulation of newly polymerized actin filaments adjacent to the plasma membrane in
most cells stimulated by growth factors (Tapon and Hall, 1997; Mitchison and Gramer,
1996).  The main function of both lamellipodia and membrane ruffle is to migrate cells in
response to the cell signals.  The lamellipodia are the cell membrane protrusions at the
leading edge of migrating cell, which gives cells more adhesive contacts to the
substratum.  They are full of meshwork of actin filaments, and the polymerization of
actin filaments is very active and dynamic within lamellipodia (Welch et al, 1997).   The
structure of membrane ruffles is similar to lamellipodia, with the difference being that the
membrane protrusions of membrane ruffles are upwards from the dorsal surface of the
cells (Ridley et al, 1999).
CDC42 stimulates the formation of filopodia (Allen et al, 1997). Filopodia are
similar to the lamellipodia in both structure and function.  They are tiny membrane
protrusions compared to the lamellipodia, and extend from the leading edge of migrating
cells and adhere to the substratum (Lauffenurger and Horwitz, 1996).
5It is not too clear how cell signals stimulate these Rho-like GTPases and
thereafter the activated Rho-like GTPases affect actin filaments.   Several protein kinases
and cellular proteins have been identified that bind to Rho-like GTPase in a GTP
dependent way and transfer the signals to actin filaments (Aelst and D’Souza-schorey,
1997).      Ser-Thr kinase p160ROK has been shown to interact with Rho, and either
overexpression or constitutive activation of p160ROK can mimic Rho activities in vivo
(Leung et al, 1996).  ERM (ezrin, radixin and moesin) has been proposed to serve as
regulatory scaffold protein to anchor both actin filaments, and Rho and Rac (Hall A,
1998).  Recently, both Ser-Thr kinase p65PAK and PIP5-kinase have been reported to be
potential Rac target proteins (Tapon et al, 1998).   Rho-like GTPases influence actin
filaments through multimolecular complexes and there are lots of cross-talk and
redundancy among them.  Identification of the individual component among these
multimolecular complexes will lead to an understanding of the fundamental cellular
processes to regulate the functions of actin filaments (Hall, 1998).
Changes of actin filaments in tumor cells
Changes in cell shape and morphology are characteristics of tumor cells.  Cell
shape is governed by actin filaments and their associated proteins (Ben-Ze’ev, 1985).  In
the process of malignant transformation, the change in cell shape could be the first
phenomena (Holme, 1990).  In most tumor cells, the pathological changes are directly
related to the alteration of actin filament integrity.  The actin filaments undergo
tremendous rearrangement and remodeling upon either RNA or DNA tumor virus
infection, or chemical carcinogen treatments (Carley et al, 1981).  The typical example is
6Src transformation.  It decreases actin filament bundles, alters the integrity of actin
filaments into dot or rosette like structure and induces the formation of lamellipodia
(Felice et al, 1990; Wang et al, 1976).
In neoplastic cells, the disordered motility is concomitant with the changes of
actin filament structures at the lead edge of malignant cells, which showed the increased
numbers of membrane ruffle and focal adhesion (Gabbiani and Gocher, 1983).  In the
development of colon carcinoma, the transition of noninvasive benign colonic tumors to
invasive malignant tumors is marked with the loss of actin filament organization.  The
benign colonic tumors, adenomas, have highly organized actin filaments and the actin
filaments are disrupted when adenomas become malignant adenocarcinomas.
Furthermore, the actin filaments undergo rearrangement and remodeling when the
preneoplastic cells from the benign adenomas are treated with tumor promoters in cell
culture.  It was thought that the disrupted actin filaments enabled colonic carcinoma cells
to be more deformable and would more easily penetrate the surrounding tissue (Friedman
et al. 1984).  Reverse experiments showed that a decrease in the tumorigenicity of rat
mammary tumor cells was concomitant with partial restoration of integrity of actin
filaments and cell surface fibronectins (Paulin et al, 1979).
Genetic studies found the alteration of cell morphology in transformed cells was
often accompanied with the decreased expression of actin binding proteins, such as
thymosin, tensin, vinculin, tropomyosin, merlin, gelsolin and l-plastin.  The restore or
increase of the expression of these actin binding proteins reverts or suppresses the
malignant phenotype of cells (Janmey and Chaponnier, 1995).
7II. Src protein kinase
Structure of Src protein kinase
                                                                           Y                     Y
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                                                                                                        Diagram of Src
c-Src is the one of the non-receptor tyrosine kinases.  It is a proto-oncogene that
functions in the regulation of cell differentiation and proliferation (Brown and Cooper,
1996).  It is composed of several functional domain structures.   At the N-terminus, there
is a myristylation domain (A), which permits c-Src to associate with cell membrane. The
membrane association is necessary for both cell signal transduction and transformation
(Kamps et al, 1986).  Downstream of the myristylation domain is a unique domain (B),
which is the most diverse domain among Src family membranes.  Its function is
unknown, however, some researchers hypothesized that it might act as a space to give
other Src protein domains a convenient distance from the cell membrane or it might be
important for the potential interactions between Src and other cellular proteins (Superti-
Furga and Courtneidge, 1995).  The protein interaction domains are located downstream
of the unique domain and are composed of SH3 domain (C, Src-homology 3) and SH2
domain ( D, Src-homology 2).   These domains play a major role in regulating Src protein
8functions.  Both SH3 domain and SH2 domain function in the protein-protein interactions
and are conserved among Src family proteins.  The SH3 domain recognizes a proline-rich
motif (Pawson and Schlessinger, 1993; Morton and Campbell, 1994).  The SH3 domain
frequently exists in the proteins which are  involved in the interactions with the
cytoskeleton and cell membrane (Drubin et al, 1990;  Rodaway et al, 1989).  Some
experimental data suggest that the SH3 domain may interact with the guanine nucleotide
exchange factors and the GTPase-activating protein, and may link Src to the small Ras-
like guanine nucleotide-binding (G) protein (Pawson and Gish, 1992).   The SH2 domain
specifically binds to tyrosine phosphorylated proteins when these phosphotyrosines are
within a specific amino acid sequence (Pendergast et al, 1991; Pawson and Gish, 1992).
Downstream of the homology domain is a kinase domain (E) that is a catalytic domain of
Src protein.  There are ATP binding sites and the tyrosine autophosphorylation sites
within this kinase domain (Parsons and Weber, 1989). c-Src has a C-terminal regulatory
domain (F) that is responsible for the negative regulation of cSrc activity by Csk in vivo.
This domain has 19 amino acids and contains a regulatory tyrosine residue at amino acid
527.  The phosphorylation of Tyr-527 by c-terminal Src kinase (Csk) results in the
interaction between phosphorylated Tyr-527 and its own SH2 domain, and this
intramolecular interaction forces c-Src to adopt the conformation to mask the kinase
domain, which keeps c-Src enzymatically inactive (Courtneidge, 1985; Cooper and
Howell, 1993;  Superti-Furga et al, 1993).  Mutation at Tyr-527 to phenylanine creates a
constitutively activated Src kinase that is sufficient to transform the cells (Parsons and
Weber, 1989).
9Oncogene v-Src
v-Src is encoded by Rous Sarcoma Virus.  It is a mutant form of c-Src without the
c-terminal negative regulatory domain.  It is an active tyrosine kinase.  vSrc
transformation increases the steady state levels of cellular tyrosine phosphorylation
(Parsons and Weber, 1989).  vSrc exhibits tyrosine kinase activity both in vivo and in
vitro and is sufficient to transform cells to become tumors (Jove and Hanafusa, 1987).
Therefore, vSrc is an onco-protein.
c-Src in cell signal transduction
c-Src  plays a major role in normal cell signal transduction.  It is involved in the
growth factor receptor tyrosine kinases (RTK) mediated signal transduction.  The auto-
phosphorylated RTKs recruit and activate c-Src upon the binding of growth factors.  The
activated c-Src might phosphorylate Shc, and then recruit Grb2 and Sos to activate the
Ras pathway ( McGlade et al, 1992; Lutterll et al, 1996).  c-Src can mediate intergrin
activated Ras pathway. The autophosphorylated intergrin recruits and activates FAK
(focal adhesion kinase) and c-Src upon the binding of fibronectin, and then the activated
c-Src eventually initiates activation of the Ras pathway (Schlaepfer and Hunter, 1996).
c-Src also links G protein coupled receptors to the Ras pathway through  Shc or Pyk2
(Luttrell et al, 1996; Dikic et al, 1996).  Recently, it was found that c-Src could activate
c-Myc via a Ras independent pathway (Barone and Courtneidge, 1995). c-Src may be
transiently activated when fibroblast cells go from G2 to M phase, and microinjections of
antibodies directly against to cSrc, and its relative kinases arrest fibroblast cells at G2
phase (Roche S, 1995), indicating c-Src may be involved in the control of cell cycle (
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Taylor and Shalloway, 1996).  It was found that c-Src could regulate EGF induced actin
filament dissembly and reassembly through the phosphorylation of  p190RhoGAP
(Chang et al, 1995).   There are some clues that c-Src may be directly involved in the NF-
kB activation through the tyrosine phosphorylation of IkB-α, which causes the
dissociation of IkB-α from the NF-kB and activates the NF-kB pathway (Imbert  et al,
1996; Eicher et al, 1994).
Phenotype change of Src transformation
Activated variants of Src, both v-Src and constitutively activated cSrc, are
sufficient for transformation.  There is a theory that transformation by Src is due to the up
regulation of normal c-Src induced signal pathways (Brown and Cooper, 1996).  There
are five phenotype changes upon Src transformation: 1) The cell’s cytoskeleton is
disrupted and reorganized; 2) The cell’s growth characteristics are changed.  The
requirement for serum in culture is reduced, and the density dependent growth regulation
is lost, and, as a consequence, the Src transformed cells are able to grow to a high cell
density; 3) The cell’s extracellular matrix is changed, the cells are able to grow in
suspension or semi-solid medium, and don’t need to attach to the substratratum to grow;
4) A lot of gene expression  levels are changed; 5) Intercellular communication is
decreased  (Parson and Weber, 1989; Jove and Hanafusa, 1987).
Src transformation changes the integrity of actin filaments
The activities of Src are related to the rearrangement of actin filaments.  During
G2/M cell cycle transition, cSrc is transiently activated and at the same time the bundles
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of actin filaments are relaxed and rearranged (Jackson et al, 1989).  Upon stimulation by
growth factors, the transient increase in kinase activity of cSrc is concomitant with an
increase in cell motility that is related to the rearrangement of actin filaments (Belsches et
al, 1997; Broome and Hunter, 1996).   cSrc is involved in the formation of receptor-
induced lamellipodia, filopodia and member ruffle (Thomas and Brugge, 1997).  cSrc
knockout cells lack both lamellipodia and member ruffle, and reintroduction of either
cSrc or kinase-defective mutant cSrc into these cells are able to fully rescue both
lamellipodia and membrane ruffle structures (Boyce et al, 1992; Schwartzberg et al,
1997). These indicate that cSrc may have the ability to regulate the rearrangement and
remodeling of actin filaments via protein interactions.
Src transformation is partially characterized by the disruption of actin filaments
(Felice et al, 1990; Reynolds et al, 1989).  Src transformation induces the formation of
lamellipodia and increases cell motility (Thomas and Brugge, 1997).   Studies found Src
transformation reduced actin filament bundles, decreased the expression of stress fibers
and disrupted the integrity of actin filaments.  Using electronmicroscope techniques,
Boschek et al, found that during the early stage of Src transformation, the cells protruded
on the dorsal cell surface as ruffle-like flowers that were full of actin filaments and actin
binding proteins, and after a while the stress fibers disappeared and the cells rounded up
(Boschek et al, 1981).
The changes in integrity of actin filaments in Src transformation are due to the
reorganization of actin filaments, instead of depolymerization of F-actin into G-actin.
Using ts-mutant Src, Felice et al, found that the amount of F-actin in cells was unchanged
between permissive (transforming ) and restrictive (nontransforming) temperature,  and
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the loss of microfilament bundles and stress fibers was due to the reorganization of
polymeric actin (F-actin) to other polymeric forms (Felice et al, 1990).   Holme found
that the formation of punctate filament aggregates was associated with the incorporation
of actin into the actin filament core fraction in Src transformation (Holme et al, 1986).
Src transformation may change the actin filaments in three ways: 1) structural cross-
linking is reduced, 2) actin filament lengths are shorter and 3) the membrane association
is weaker (Felice et al, 1990).
The mechanisms by which Src affects the actin filaments is not clear.  There are
several Src substrates that may be involved in mediating the effects of Src upon actin
filaments.  The Src substrate cortactin may be one of these candidates.  It is an F-actin
cross-linking protein and is enriched in lamellipodia and membrane ruffles.  In vitro, both
cortactin’s F-actin cross-link and binding activities are reduced upon tyrosine
phosphorylation of cortactin by Src. (Huang et al, 1997).   Another Src substrate is
vinculin.  It is an actin binding protein and attaches actin filaments to the plasma
membrane.  Research found that tyrosine phosphorylation of vinculin by Src might have
some functional roles in the disruption of actin filaments, and the changes of cell shape
and adhesion (Sefton et al, 1981).  Gelsolin is the most thoroughly studied actin binding
protein.  It is an actin filament severing, capping and nucleation protein.  It is also a PIP2-
dependent substrate of Src, and PI 3 kinase associated gelsolin can form a stable complex
with Src.   Gelsolin severs the assembled actin filaments, caps both free actin (filaments)
and newly severed actin filaments.  The activity of gelsolin is regulated by Ca2+, Mg2+
binding and phosphoinositides.  It has been hypothesized that Src might have some
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regulatory roles in gelsolin mediated dynamic changes of the integrity of actin filaments
(Kwiatkowski DJ, 1999; De Corte et al, 1997 and 1999).
III. Types of actin binding protein
There are enormous amounts of actin binding proteins in eukaryotic cells, and
they play major roles in a wide variety of cell processes in vivo. Functionally, the actin
binding proteins can be divided into two major catalogs: regulatory proteins which are
involved in the regulation of dynamic assembly and disassembly of actin filaments, and
structural proteins which are involved in stabilizing actin filaments and constructing cell
structures (Ayscough KR, 1998).  Some examples include tropomyosin, which binds
along with actin filaments to mediate cell movement; fimbrin, which cross-links and
bundles actin filaments to form high order structure;  ABD-120, which cross-links actin
filaments to form gel-like networks; myosin, which binds actin filaments to involve in
cell contraction and profilin, which binds to G-actin to sequest G-actin and to regulate
actin polymerization.  Both capping protein (CP) and gelsolin cap and sever actin
filaments to regulate the growth rate of actin filaments (Ayscough KR, 1998).  I will
summarize the types of actin binding proteins into three major classes same as the order
of recent review papers (Taylor et al, 1998; Puius et al, 1998; Ayscough KR, 1998).
Actin cross-linking proteins
Actin cross-link proteins usually bind to and cross-link actin filaments by using
two discrete actin binding domains to control cell morphology and motility.  Some of
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these proteins themselves have two actin binding domains like fimbrin, and some
proteins have only one actin binding domain and create two actin binding domains by
forming non-covalent dimers, like α actinin and ABP-120.  These proteins share a
common actin binding domain that contains 250 amino acids and is composed of two
tandem repeat calponin homology (CH) domains and a helix connector. Each CH domain
is composed of six helical structures (Castresana and Saraste , 1995).  The two actin
binding domains are tightly linked to each other.  Fimbrin’s two actin binding domains
are closely located on the same polypeptide chain in a tandem manner, and both α-actinin
and ABD-120 form homodimers and two actin binding domains are tightly bound to the
dimerization core structure that is arranged in head-to-tail fashion.  These topologies
rigidly pack the cross-linked actin filaments when two actin binding domains bind to
actin filaments individually (Puius et al, 1998).
These actin cross-linking proteins not only direct the construction of actin
filament network, but also involve in regulating cellular functions, which are modulated
by the concentrations of cross-link proteins and calcium (De Arrudea et al, 1990).
Actin severing and capping proteins
Both actin severing and capping proteins are the most dynamic actin binding
proteins to regulate the assembly and disassembly of actin filaments in vivo.  There are
two major families: gelsolin family and cofilin family.  Their functions are regulated by
calcium, polyphosphoinositdes and pH (Puius et al, 1998).  Structurally, they share a 15
kDa common actin binding domain.  The secondary structure of this actin binding
domain is known.  It is composed of a central five stranded β-sheets, flanked by a
15
paralleled long helix.  There is a short helix located perpendicularly against the central β-
sheets  (Puius et al, 1998).   Usually, these proteins have three to six repeat 15 kDa actin
binding domains, which are coordinately involved in several different functions.
G-actin binding proteins
Examples of G-actin binding proteins are profilin and gelsolin.  They regulate
actin filaments through monomer sequestration, nucleation and catalytic enhancement of
ADP/ATP exchange.   There is no clear sequence identity of actin binding domains
among profilin family members, but it was found that the overall structure of actin
binding domains of the profilin family were the same as the secondary structure of
gelsolin’s 15 kDa actin binding domain modular (M Van Troy et al, 1999; McLaughlin
and Weeds, 1995). Interestingly, profilin can bind to proline rich sequence in actin
filaments and competitively bind to other proline rich sequences with SH3 and WW
domains in vitro.  It implies that profilin may be involved in transferring multiple signals
from SH3 and WW domain containing proteins to actin filaments (Mahoney and Almo,
1998).
Consensus sequences for actin binding domains (Taylor et al, 1998)
Actin binding domain-1 (ABD-1) is a conserved 26 amino acid sequence among
actin binding domain of actin cross-link proteins.  In vitro studies found the polypeptide
representing this conserved sequence is sufficient to bind to actin filaments (Kd 4µM).
The actin cross linking proteins that have this consensus sequence are spectrin,
dystrophin, fimbrin, filmin and tensin (see Table 1 of Taylor et al, 1998).
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Actin binding domain-2 (ABD-2) is a conserved basic amino acid sequence
(KYKXL; K=K/R) among actin binding domains of capping proteins and G-actin binding
proteins.  The actin binding proteins that have this consensus sequence are radixin, tensin,
talin, capping protein (CP), gelsolin and profilin (see Table 1 of Taylor et al, 1998).
Actin binding domain-3 (ABD-3) has a consensus sequence KLKR.  It exists in
some F-actin binding proteins such as VASP, vinculin, thymosin β4, villin and dementin
(see Table 1 of Taylor et al, 1998).
IV. AFAP-110
Structure of AFAP-110
               A      B C D        E                F              G        H           I
                                                                                           Diagram of AFAP-110
AFAP-110 is an acronym for an actin-filament-associated protein of 110 kDa. It
has 637 amino acids and is composed of several protein signaling motifs (Flynn et al,
1993; Qian et al, 1998).  Fragment A (between amino acid 1-61) has an unknown
function. Fragment B (between 62 and 71) is a SH3 binding motif. The SH3 binding
domain  is  defined as proline-rich sequences of 10 amino acids in length (Ren et al,
1993). There is a conserved a PXXP structure at the 7-10th residues within the proline
17
rich motif, forming ppII helix.  The two conserved prolines directly bind to the SH3
domain of Src, and other residues serve as a molecular scaffold to promote the formation
of the ppII helix (Yu et al, 1994).  The two XX residues are generally composed of
hydrophobic residues.  Fragment C (between 75 and 84) is a proline rich sequence and a
possible WW domain binding site (Sudd, personal communication).  There are two SH2
binding motifs in AFAP-110 (D and H, between 85-152 and 450-510) (Guappone et al,
1998).  The first proposed Src family SH2 binding motif was YPXEI (Cantley et al,
1991).  Later it was found that the unique sequence of the Src SH2 binding motif was
pTyr-x-x, here at least one x residue is acidic and hydrophilic(Songyang et al, 1993).
Recently, it was confirmed that the Src SH2 binding motif was YP-AEI (Eide et al, 1995).
There are two pleckstrin homology (PH) domains (E and G, between 153-248 and 347-
450) (Gibson et al, 1994; Shaw, 1996; Ma et al, 1997).  The PH domain was originally
named for the pleckstrin.  Both the pleckstrin’s N and C termini  are the prototypes of the
PH domain and they are about 100 amino acids in size (Musacchio et al, 1993).  This
domain is mainly found in signaling and cytoskeleton proteins.   Many  Ser/Thr-
phosphorylated proteins, such as  pleckstrin and spectrin, have this domain (Gilson et al,
1994).   Its function is not clear, but it was proposed that it might interact with the plasma
membrane, the organeller membranes, the βγ- complexes of heterotrimeric G protein and
the protein kinase C (Gibson et al, 1994).  Some researchers found that the PH domain
could recognize the short peptide chains with phosphorylated serine and/or threonine
residues (Fowler and Adam, 1992).  Between the two PH domains of AFAP-110, there is
a serine/threonine kinase substrate region (F, between 210-360) (Flynn et al, 1993).  This
region is rich in serine and threonine residues.  Of these serine and threonine residues, 15
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are postulated to be the phosphorylation sites of protein kinase C.  The presence of this
region indicates that AFAP-110 may be a substrate of protein kinase C and other
serine/threonine kinase.  At the C-terminal domain (I, between 511-637), there is a
Leucine zipper motif (Qian et al, 1998)and two actin binding domains (ABD-1 and ABD-
3) (Qian et al, submitted).
Leucine Zipper Motif
Leucine zipper motif was first discovered in dimerized DNA binding proteins in
1988 (Landschultz et al, 1988).  Later it was found in both transcription factors and
cytoskeleton proteins ( Hurst, 1994). It is composed of two amphipathic, right handed α-
helices.  It was first hypothesized that the leucine zipper motif functions through its two
helical side chain interaction with each other to form zipper like structure and later
nuclear magnetic resonance and X-ray studies confirmed the leucine zipper motif existed
as the coiled coil structure (Oas et al, 1990; O’SHEA et al, 1991).  The difference
between the general coiled coil structure and the leucine zipper motif is that the leucine
zipper motif has the highly conserved leucine residues while the general coiled coil
structure substitutes these conserved leucines with other hydrophobic residues
(Kouzarides et al, 1991).
The leucine zipper motif is composed of two right handed α-helices, and each of
α-helix is composed of 30-40 amino acids and contains a repeating heptad pattern of
sequence designated by amino acid positions (abcdefg)n ( Alber, 1992). The general
right handed α helix is usually composed of 3.6 residues per turn while the right handed
α helix of leucine zipper motif undergoes a twist in a left hand fashion.  Thus, there are
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3.5 residues per turn in the right α-helix of leucine zipper motif, and two turns constitute
one heptad repeat (Lupas, 1996).  The conserved hydrophobic leucine is always at
position d and the alternate hydrophobic residue is located at position a ( see diagram
below) (Alber, 1992).   These alternated hydrophobic resides are often composed by β-
branched amino acids: valine, threonine and isoleucine (Alber, 1992).  So each conserved
leucine residue locates three residues after and four residues before the alternate
hydrophobic residue, and, as a result, forms 4/3 hydrophobic residue repeats (Hodges,
1992).   These bulky hydrophobic residues form a continuous hydrophobic core structure
and their side chains are buried inside (O’Shea et al, 1991).  With the above basic
sequence structure, the leucine zipper motif forms the coiled-coil structure by
hydrophobic force.
 
                                     Diagram of the leucine zipper motif (modified from Alber, 1992)
a
a’d
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c
b
b
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g
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There are some intra- and inter-ionic interactions that contribute to the
stabilization of the dimer.  The ionic attractions and repulsion between g-e’ and e-g’ help
to maintain the dimerization, and the zero net charge between two monomers’ inner faces
favored the dimerization too (see diagram above) (Stone et al, 1978; O’Shea et al, 1992).
The amino acids (g) ahead of the alternative hydrophobic residues and the amino acids
(e) after the next conserved leucines are opposite charged (Letai and Fuches, 1994).
These opposite charged residues are spaced by exactly four residues.  Biochemical
studies found that they could form intra ion pairs within the helical monomer, and also
form inter ion pairs between the two monomers (Letai and Fuches, 1994).
There is a conserved polar residue, asparagine, in the center of the leucine zipper
motif and it is usually located at the alternate hydrophobic position a (Alber, 1992).  This
asparagine has three important functions (Alber, 1992): First, this asparagine creates the
force to maintain the helices to be parallel and in register; Second, the interaction
between this asparagine and another polar residue of binding partner determine the
specificity of dimerization; Third, this asparagine also destabilizes the dimer, as the
replacement of Asn16 in the GCN4 leucine zipper by valine dramatically stabilizes the
dimerization.  It was thought that this destabilization could allow for more rapid
reassortment of dimer proteins.
The leucine zipper motif is involved in both  homo- and  hetero-dimerization, and
the dimers can be in either parallel or antiparallel fashion.   If the dimer is formed in
parallel, the conserved leucine (d )  interacts with another monomer’s alternate
hydrophobic residue (a’) and,  at the same time, the another monomer’s conserved
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leucine (d’) contacts with its counterpart (a).  If the dimer is formed antiparallel, d and a
interact with d’ and a’, respectively (see diagram below) (Alber, 1992).
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                                                               Diagram of homodimerization of the leucine zipper motif
Leucine zipper motif plays a major role in the formation of keratin filaments,
neurofilament and vimentin filaments.  All of them have the same basic structure that is
consisted of several long leucine zipper motifs and some short irregular regions
interspersed within these long leucine zipper motifs (Steinett et al, 1994).   Each protein
subunit first interacts with each other to form dimers through leucine zipper motifs, and
then the leucine zipper motifs within the dimers mediate the formation of bundle filament
structures that are in antiparallel and axial register (Parry et al, 1985; Kouklis, 1992).
Leucine zipper motifs can function as the structural linkers for the cellular
apparatuses from different cell compartments.  One example is the complicated
interactions of tropomyosin, troponin T, myosin and dystrophin.  Both the tropomyosin
and the myosin are actin binding proteins, troponin T is a skeletal muscle protein and
dystrophin is a muscle-membrane cytoskeleton protein.  All of these proteins have
leucine zipper motifs and form homodimers.   They interact with each other to form
heterodimers through the leucine zipper motifs.  The tropomyosin interacts with the
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troponin T through their leucine zipper motifs and this tropomyosin:troponin T complex
regulates the myosin’s binding to the actin filaments in  a Ca2+ dependent manner
(Hitchcock-DeGregori and An, 1996). The dystrophin dimerizes with both the
oligomeric, membrane-spanning protein complex (β-dystroglycan, syntrophine and α-
dystroglycan) and troponin T through the leucine zipper motifs to link the muscle cell
membrane to the contractile apparatus (Blake et al, 1995 and Pearlman et al, 1994).
Zipper protein is a newly cloned tropomyosin like protein.  There is a leucine zipper
motif in its cytoplasm tail.  The leucine zipper motifs mediate the binding of brush-border
myosin to the actin filaments at the intestinal brush border same as the tropomyosin
regulates the actin filament-myosin interactions (Bikle et al, 1996).
Leucine zipper motifs are also involved in the intercellular junctions.
Desmoplakin is one of major component proteins within desmosomes.  It links many
cells together through the association with intermediate filaments among adjacent cells.
The main force to mediate this interaction is the leucine zipper motif that locates at the n-
terminus of desmoplakin.  Desmoplakin has a long leucine zipper motif and the
conserved charged amino acids within the long leucine zipper motif form the heptad
charge repeats.  The heptad charge repeats of amino acids match well with that of the
intermediate filaments, and the electoral interactions are then formed to link the
desmosomes to the intermediate filaments (Green et al, 1990).
AFAP-110 may mediate the effect of Src upon actin filaments
AFAP-110 was first identified as a 110-kDa protein that forms a stable complex
with activated variants of Src (Reynolds et al, 1989).  Kanner et al (1991) found that Src
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transformation not only increased tyrosine phosphorylation of AFAP-110, but also
increased serine/threonine phosphorylation of AFAP-110.   The domain structure of
AFAP-110 indicates AFAP-110 may have the capability to facilitate the effects of
multiple signal proteins upon actin filaments.  Immunoprecipitation shows that AFAP-
110 can bind to Src, and immunoflurosecence shows AFAP-110 associates with actin
filaments and the cortical actin matrix in both normal and transformed chick embryo
fibroblast (CE) cells, indicating that AFAP-110 is both a Src substrate and actin filament
associated protein (Flynn et al, 1992; Flynn et al, 1993).  The transformation of CE cells
by v-Src is coincident with an increase of tyrosine phosphorylation and relocalization of
AFAP-110, and the rearrangement of the actin filaments into rosette-like structure (Flynn
et al, 1993).  The interaction between Src and AFAP-110 depends upon SH3 and/or SH2
domains (Kanner et al, 1991; Reynolds et al, 1987; Guoppone et al, 1998).
Transformation of SH2 and SH3 deletion mutants of Src has no change of the localization
of AFAP-110 and the integrity of actin filaments in vivo and AFAP-110 was unable to
form a stable complex with either SH2 or SH3 deletion mutants of Src, or kinase
inactivated Src in vitro (Kanner et al, 1991; Reynolds et al, 1987).  Protein binding assay
shows GST-SH3 can affinity absorb AFAP-110, but is unable to absorb tyrosine
phosphorylated AFAP-110, indicating Src transformation may induce a conformational
change within AFAP-110 (Flynn et al, 1993).    Taken together, these data indicate that
AFAP-110 may have the ability to mediate the effects of Src (and other cellular signal
proteins) upon actin filaments.
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V. Overall goals of this thesis.
1) AFAP-110 has an alternatively process form in vivo, named AFAP-120 (Flynn
et al,1995).  AFAP-120 encodes an additional 86 amino acids compared to AFAP-110,
and these 86 amino acids are inserted just amino terminal to the carboxy terminal 127
amino acids of AFAP-110.  The carboxy terminus is conserved between AFAP-110 and
AFAP-120.  It indicates that the carboxy terminus is important for AFAP-110.  In this
thesis, we studied the functional roles of the carboxy terminus of AFAP-110.
2)AFAP-110 has been shown to colocalize with actin filaments in vivo in chicken
embryo fibroblast (CE) cells (Flynn et al, 1993).  However, we don’t know whether
AFAP-110 interacts with actin filaments directly or indirectly.  In this thesis, we tested
whether AFAP-110 interacts with actin filaments directly.
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Abstract
The SH2/SH3 binding partner AFAP-110 is a tyrosine phosphorylated substrate
of Src.  It has the ability to modulate the integrity of actin filaments.  AFAP-110 has
several protein signal domains.  It has a SH3 binding motif, two SH2 binding motifs and
two PH domains at its amino terminus, and has a leucine zipper motif at its carboxy
terminus.  There are two monoclonal antibodies to recognize AFAP-110.  Mab 4C3
recognizes the amino terminus of AFAP-110 while Mab AFAP-110 recognizes the
carboxy terminus of AFAP-110.  Site directed mutagenesis of prolines at SH3 binding
motif and the adjacent proline rich motif abrogates Mab 4C3 binding, and this same
mutation has been shown to prevent SH3 interactions between Src527F and AFAP-110,
indicating the epitope of Mab 4C3 is within SH3 binding motif.  Importantly, Mab 4C3 is
unable to efficiently react with mammalian AFAP-110.  Sequence analysis of the amino
terminus of putative human AFAP-110 reveals two amino acid differences compared to
that of avian of AFAP-110, indicating a mechanism for species-specific binding for Mab
4C3.   Mab AFAP-110 recognizes AFAP-110 across the species, and its epitope is
located at the carboxy terminus of AFAP-110, including and around the 5th leucine of the
leucine zipper motif heptad repeat.  The leucine zipper motif may mediate AFAP-110’s
self-association and regulate the function of AFAP-110.  These two monoclonal
antibodies are useful tools to study AFAP-110 in the regulation of cell morphology and
the actin filament integrity.  In addition, Mab 4C3 may be used to study the function of
avian AFAP-110 expressed in mammalian cells by providing an internal epitope tag.
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Introduction
One of hallmarks of Src transformation is the disruption of actin filaments
(Reynolds et al, 1989 and Felice et al, 1990).  AFAP-110 (Actin Filament Associated
Protein, 110kDa) is both a Src substrate and an actin binding protein (Flynn et al, 1993).
It is a candidate protein to mediate the effects of Src on the integrity of actin filaments.
Early studies found that AFAP-110 was located on actin filaments, cortical actin matrix
and the leading edge of the cell (Flynn et al, 1993).  Immunofluorescence found that the
carboxy terminal 84 amino acids within AFAP-110 were essential for the binding to actin
filaments (Qian et al, 1998).  Deletion of the leucine zipper motif within these 84 amino
acids, followed by cellular expression, results in actin filaments being repositioned into
rosette like structures, this mutated AFAP-110 still locates with the altered actin
filaments (Qian et al, 1998).  These data indicate that AFAP-110 is capable of binding to
actin filaments, which is mediated through carboxy terminal 84 amino acids.  They also
indicate that AFAP-110 may have an intrinsic ability to alter the integrity of actin
filaments, which is regulated by the leucine zipper motif within the carboxy terminal 84
amino acids.  It is our hypothesis that AFAP-110 may mediate the effects of Src
transformation, and other cellular signals, upon actin filaments.
AFAP-110 has both SH3 and SH2 binding motifs and is a SH3/SH2 binding
partner for Src527F (Flynn et al, 1993; Reynolds et al, 1989; Kanner et al, 1991; Guappone
and Flynn, 1997 and Guappone et al, 1998).  It was found that tyrosine phosphorylated
AFAP-110 could form a stable complex with activated variants of Src (such as Src527F) in
primary cultures of chick embryo fibroblast (CE) and rat lung embryo fibroblast cells
40
(Flynn et al, 1993 and Liu et al, 1996).  There is an SH3 binding motif within AFAP-110
between amino acids 62-71, and adjacent to the SH3 domain is a proline rich motif
between amino acids 75-84.   Earlier data showed that the integrity of SH3 binding motif
is important for the binding of Src527F to AFAP-110 while the adjacent proline rich motif
is not necessary for the binding.  AFAP-110 also contains two SH2 binding motifs at
Tyr94 and Tyr451/453 (Guappone et al, 1998).  The interaction of Src527F with AFAP-110 is
also dependent on the integrity of either of these two SH2 binding motifs.  Therefore, the
formation of a stable complex depends on the integrity of both SH2 and SH3 interactions.
AFAP-110 also contains two pleckstrin homology (PH) domains (Gibson et al, 1994 and
Shaw G, 1996) and a serine/threonine kinase substrate region between two PH domains
(Flynn et al, 1993).  Thus, it is possible that AFAP-110 may be involved in transferring
cellular signals from different signaling pathways to actin filaments, which may affect the
integrity of actin filaments.
Currently, there are three different kinds of antibodies to AFAP-110.  They are
MAb 4C3, polyclonal Ab F1 and MAb anti-AFAP-110.  The early work by Kanner et al
led to the development of MAb 4C3, which is reactive with an epitope in the amino
terminus of AFAP-110 (Kanner et al, 1990).  Using MAb 4C3, Flynn et al screened λ
gt11c cDNA library to get a cDNA that expresses an immunoreactive epitope, defined as
amino acid 53-356 (Flynn et al, 1993).  Polyclonal antibody F1 was created using this
fragment of amino acids to immunize the animal (Flynn et al, 1993).  Monoclonal
antibody MAb anti-AFAP-110 was made against the carboxy terminal amino acids 469-
637.  Interestingly, MAb 4C3 can only react with avian isoform of AFAP-110.  Neither
the murine isoform nor human isoforms of AFAP-110 are reactive with MAb 4C3 (Flynn
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et al, 1993 and Kanner et al, 1990), while both polyclonal Ab F1 and MAb antiAFAP-
110 can react with avian, murine and human isoforms of AFAP-110.  Therefore, the
immunoreactive epitope for MAb 4C3 may be unique for the avian isoform of AFAP-
110.
In this paper, we report two MAbs, MAb 4C3 and MAb anti-AFAP-110,
recognize epitopes that are defined as functional domains within AFAP-110.  MAb 4C3
recognizes the partial SH3 binding domain of avian AFAP-110 that has two amino acid
differences from the predicted sequence of putative human AFAP-110.   MAb anti-
AFAP-110 recognizes an epitope within carboxy terminal leucine zipper motif that is
adjacent to the actin binding domain.
Materials and Methods
Generation of antibodies
MAb was created as previously described (Kanner et al, 1990 and 1989).  Src
transformed CE cell lysates were immunoprecipitiated by anti-tyrosine antibody to fish
out tyrosine phosphorylated proteins.  The precipitated proteins were purified,
concentrated and injected into mice.   The resulting MAbs recognized a panel of Src
substrates.  The MAb that recognized AFAP-110 was named as MAb 4C3.   Ab F1 was
created as previously described.  MAb Anti-AFAP-110 was developed by Transduction
Labs, Inc. (Lexington, KY) by challenging mice with fusion protein containing carboxy
terminal amino acids 469-637 of avian isoform of AFAP-110.  (See Transduction
Laboratories 1998 Antibodies catalog, page 43).
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Generation of point and deletion mutants and expression vectors
Point mutations were generated using the Muta-Gene phagemid in vitro
mutagenesis kit (Bio-Rad laboratories, Richmond, CA) as previously described
(Guappone and Flynn, 1997).  Oligonucleotides were synthesized that were 18bp in
length and contained a single mismatch to mutate a specific proline residue to alanine.  In
the SH3 binding motif (SH3bm I),  Pro71 was mutated to Ala (referred to as AFAP71A),
while Pro77 was mutated to Ala (referred to as AFAP77A) in the adjacent proline rich
sequence.   In addition, a double mutant was created, referred as AFAP71/77A.  Deletion of
the carboxy terminal 84, 44, 22 amino acids were accomplished by generation of a stop
codon in place of Lys554, Lys593 and Lys616, respectively (Qian et al, 1998 and Qian et al,
unpublished data).  The leucine zipper motif was removed by deleting amino acids 559-
593, as previously described (Qian et al, 1998).
Both the wild type of AFAP-110 and different mutant AFAP-110s were
subcloned into pCMV-1 expression vector, under the control of CMV promoter as
previously described (Guappone et al, 1996).
Cell culture and expression of cDNA constructs in CE, C3H10T1/2 and Cos-1 cells.
Both CE cells and Cos-1 cells are maintained as previously described (Flynn et al,
1993).  C3H10T1/2 cells are maintained in Dulbecco’s modified eagle’s minimal
essential medium (DMEM) containing 5% fetal calf serum, 2µM glutamine, and 1%
penicillin/streptomycin, as previously described (Guappone et al, 1996 and Luttrell et al,
1988).  The different AFAP-110s were transfected into Cos-1 cells using the method as
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Chen and Okayama described (Guappone et al, 1996; Chen and Okayama, 1987), and
transfected into C3H10T1/2 cells using Superfectamine (Qiagen, Corp., Valencia, CA).
The efficiency of transfection is around 1-5% of total cells.
RCAS-AFAP1-145 was generated by deleting bp 452-2260 of AFAP-110.  Deletion
was accomplished as described below. pKS(+/-)-AFAP-110 was digested with StuI and
religated, and the resulting construct was cut with ClaI and shuttled into pRCAS via
unique ClaI site.  The construct expressed amino acids 1-145 of AFAP-110 plus three
novel amino acids and a stop codon. RCAS-AFAP1-145 was transfected into CE as
previously described (Boyer et al, 1993), with the resulting avian retrovirus infected all
cells by day 12 post-transfection (Flynn et al, 1993). Using polyclonal Ab F1, Western
Blot analysis was applied to detect the presence of 37-kDa immunoreactive polypeptide
to confirm the expression of AFAP1-145 .
Generation of GST-encoded fusion proteins and competitive inhibition
GST-SH3 was generated from the avian form of c-Src, as previously described
(Flynn et al, 1993).  The preparation of bacterial lysates containing the encoded fusion
protein, and immobilization on glutathione-sepharose beads were done according to the
method of Smith and Johnson (Smith and Johnson, 1988).  Twenty micoliters of
sonicated and centrifuged bacterial lysates were mixed with 100µl of glutathione coated
sepharose beads (pharmacia, Uppsala, Sweden; 50% w/v in MTPBS-1% Triton: 150mM
NaCl, 16mM Na2HPO4, 4mM NaH2PO4, pH 7.3) for 1 hour at 4°C.  The beads were
washed 4 times with 200 µl MTPBS-1% Triton and resuspended to 100 µl with MTPBS-
1% Triton.  The resulting 100 µl of glutathione-sepharose bead conjugated to fusion
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proteins were mixed for 1.5 hr, 4°C, with 250-500 µg (1.0 µg/µl) cellular lysates that had
been lysed in RIPA lysis buffer.  The beads were washed two times with RIPA lysis
buffer and two times with Tris-buffered saline (pH 7.3), resuspended in 100 µl 2x
Laemmli sample buffer, boiled for 5 minutes to remove bound proteins, centrifuged and
the supernatant was processed for western blot analysis.  Competitive inhibition of
affinity absorption of AFAP-110, or AFAP1-145, by GST-SH3src was achieved by pre-
incubating CE cellular lysates containing AFAP-110 with 1 µl of mAb 4C3 ascites or 1.2
µg of Ab F1 (1.2µg/µl) in 500 µl of CE cell lysate (500 µg/ml) for 2 hr, followed by
affinity absorption with GST-SH3src. Bound AFAP-110 was eluted by boiling the
immobilized proteins in 50 µl of 2x Laemelli sample buffer, bound proteins resolved by
8% SDS-Page, subjected to western transfer and western blot analysis with Ab F1.
Affinity absorption of AFAP1-145 was achieved in an identical fashion.
Protein characterization, analysis and immunofluorescence localization
Cos-1 cellular lysates were prepared using NP-40 lysis buffer (1% NP-40, 150
mM NaCl, 50 mM Tris, pH 7.5) containing protease and phosphatase inhibitors, as
previously described (Guappone et al, 996)).  Isolation of immune complexes, western
transfer and western blot analysis with Ab F1, mAb 4C3 or mAb anti-AFAP-110,
followed by quantitation using HRP-conjugated secondary antibody were done as
previously described, using chemiluminescence technology for detection (Guappone and
Flynn, 1997).  Cells were processed for immunofluorescence localization as previously
described (Qian et al, 1998 and Qian et al, unpublished data).
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Results
MAb 4C3 recognizes an epitope within AFAP-110 that contains the Src SH3 binding
motif.
The early immunoprecipitation experiments showed that specific antibodies to Src
can co-precipitate AFAP-110 in Src transformed CE cell lysates, while the reverse
experiments can not co-precipitate Src (Flynn et al, 1993).  Here, either MAb 4C3 or F1
was used to precipitate AFAP-110 from Src transformed CE cell lysates, and there was
no detectable associated Src527F with AFAP-110.    It was demonstrated that AFAP-110
can directly associate with kinase activated Src, and no other protein binding partners
were needed to mediate formation of AFAP-110/Src527F complex (Guappone and Flynn,
1997 and Guappone et al, 1998).  This indicates that both MAb 4C3 and F1 may bind
competitively to an epitope that is also the site for Src binding. Thus, both MAb 4C3 and
F1 may selectively bind to AFAP-110 that is not in association with Src.
Src binds to AFAP-110 through both the SH3 binding motif (amino acids 62-71)
and SH2 binding motif (phosphorylated Tyr94 and/or Tyr451/453) (Guappone and Flynn,
1997 and Guappone et al, 1998).  In order to determine whether MAb 4C3 and F1 reacted
with either of these epitopes, 500µg of CE cell lysates were first preincubated with either
1 µl of MAb 4C3 or 1.2µl of F1, and then absorbed by either GST-SH3Src or GST (Fig 1).
The data show GST-SH3Src binds to AFAP-110 (Fig 1A, Lane 4) while there is no
binding for GST (Fig 1A, Lane5).  However, the preincubation of CE cell lysates with
either MAb 4C3 or F1 reduces the binding activities of AFAP-110 by GST-SH3Src (Fig
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1A, lane 2 and 3). There is no effect upon preincubation of preimmune rabbit antibodies
(data not shown).  A polypeptide representing amino acids 1-145 of AFAP-110 was
subcloned into the pRCAS expression vector and the construct was transfected into CE
cells.  Similar results were obtained indicating that the binding activities of GST-SH3Src
to AFAP-110 were reduced when AFAP-110 (1-145) was preincubated with either MAb
4C3 or F1(Fig 1B).  The scanning densitometry showed MAb 4C3 reduced GST-SH3Src
binding activities to AFAP-110 about three-fold, while F1 reduce the binding activities
about two-fold, which approximated background detection levels of AFAP-110 that non
specifically bound to GST (Fig. 1C).  There is no effect on the affinity absorption of
AFAP-110 by GST-SH2Src when AFAP-110 is preincubated with either MAb 4C3 or F1
(data not shown).  These data indicate that the epitopes of both MAb 4C3 and F1 may be
located within AFAP-110’s SH3 binding motif, or the binding of either MAb 4C3 or F1
to AFAP-110 induces a confirmation change within AFAP-110’s SH3 binding motif.
In order to determine whether MAb 4C3’s epitope is located within the SH3
binding motif, site-directed mutagenesis was used to make mutant AFAP-110s.  AFAP71A
has mutation within SH3 binding motif, AFAP77A has mutation at the adjacent proline
rich motif while AFAP71A/77A is double mutant.  These mutants were transfected into Cos-
1 cells to express the proteins as previously described (Guappone and Flynn, 1997).
Western blot analysis was applied to determine the expression of mutant AFAP-110s by
using either MAb 4C3 or F1.  Data show F1 is able to detect both normal AFAP-110 and
different mutated AFAP-110s, which demonstrates the successful expression of each
construct (Fig 2A, Lane 1-4).   MAb 4C3 is able to recognize normal AFAP-110, but is
deficient in recognization of both AFAP71A and AFAP77A (Fig 2B, lane 2and 3).  MAb
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4C3 is also unable to recognize the AFAP71/77A mutant (Fig 2B, lane 4).  These data
indicate MAb 4C3’s epitope is located within the SH3 binding motif and part of the
adjacent proline rich sequence, which is defined between amino acids 71 to 77.
MAb 4C3 specifically recognizes avian isoform of AFAP-110 and doesn’t
efficiently recognize the mammalian homolog.  Immunofluorescence was applied to
determine MAb 4C3’s specificity for the avian isoform of AFAP-110 (Reynolds et al,
1989 and Felice et al, 1990).  First, normal murine C3H10T1/2 cells were labeled with F1
to detect endogenous AFAP-110, followed by anti-rabbit antibody conjugated to
rhodamine, and phalloidin conjugated to FITC to label actin filaments.  It was found that
endogenous AFAP-110 co-localized with actin filaments (Fig. 3A and AB).  Then,
C3H10T1/2 cells were transfected with avian AFAP-110 cDNA and labeled with MAb
4C3 to detect AFAP-110, followed by anti-rabbit antibody conjugated to rhodamine, and
phalloidin conjugated to FITC to label actin filaments.  The data show MAb 4C3 only
recognize the avian construct in a subset of cells successfully transfected with the avian
AFAP-110 cDNA (Fig. 3C) and this avian AFAP-110 is also colocalize with actin
filaments (Fig 3D).
Kuneida et al, found an unknown cDNA sequence of 75 amino acids called Urf
that is 94% homologous to avian AFAP-110 predicted amino acid sequence (Table 1)
(Kuneida et al, 1991).   The Urf sequence is from human stomach tumor and is predicted
to fuse to the kinase domain of the receptor tyrosine kinase Ret.  Recently, Liu et al,
isolated the human isoform of AFAP-110, and Urf sequence turned out to be identical to
the 75 amino acids of human isoform of AFAP-110 (Liu et al, personal communication).
The predicated amino acid sequence of Urf indicates a Pro residue at amino acid position
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73, while avian isoform of AFAP-110 has a Gln residue at the same position.  This
implies that amino acid Gln at position 73 may be essential for MAb reactivity with
AFAP-110.
MAb anti-AFAP-110 recognizes an epitope in the carboxy terminal leucine zipper
motif
The MAb anti-AFAP-110 was generated against the carboxy terminal 167 amino
acid sequence that is defined as amino acids 469 to 637.  This sequence contains the
leucine zipper motif and long α-helix (Fig. 4A).  The carboxy terminal mutants of AFAP-
110 were generated (Fig. 4B).  AFAP∆22 lacks last twenty two amino acids of the carboxy
terminus, AFAP∆44 lacks last fourty four amino acids of the carboxy terminus, AFAP∆lzip
has no leucine zipper motif and AFAP∆84 has neither leucine zipple motif nor long α-
helix.   These different mutants were transfected into Cos-1 cells as previously described.
The Cos-1 cell lysates were resolved by SDS-PAGE.  Western blot was applied to detect
the deletion mutants of AFAP-110, using F1 and MAb anti-AFAP-110 (Fig. 5).  F1 was
used to measure the expression levels of different forms of AFAP-110s (Fig 5, lane 1-5).
The data determined the Mr of the deletion mutants as well as an 82 kDa polypeptide that
was hypothesized to be a proteolytic breakdown product of AFAP-110 as before (Flynn
et al, 1995).  Western blot using MAb anti-AFAP-110 only detected AFAP-110 and
AFAP∆22.  Neither AFAP∆44, AFAP∆lzip nor AFAP∆84 were recognized by MAb anti-
AFAP-110.  The only common sequence that AFAP∆44, AFAP∆lzip and AFAP∆84 each
lack is Lys593, which is part of the 5th heptad repeat in the leucine zipper motif.  These
data indicate that Lys593 is a part of the epitope for MAb anti-AFAP-110.
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There is an 82 kDa polypeptide found in Cos-1 lysates (Fig. 5, lane 5A), and this
82-kDa polypeptide was also detected in CE cells.  It was hypothesized to be as a
proteolytic breakdown product (Flynn et al, 1993; Guappone and Flynn, 1997; Flynn et
al, 1995).  MAb anti-AFAP-110 is unable to detect this proteolytic product in both
AFAP-110 and AFAP∆22.  This indicates 82 kDa proteolytic product may lack carboxy
terminal sequence.  AFAP∆84 has a similar or slightly retarded Mr compared with this
proteolytic product.  This implies that the loss of carboxy terminal sequence may result
from loss of upstream sequence at or near Tyr553 (Fig.5A, lane 2).
Discussion
The data in this report demonstrate that MAb 4C3, polyclonal F1 and MAb anti-
AFAP-110 each recognize different epitopes within AFAP-110.  Preincubation of CE cell
lysates with either MAb 4C3 or F1 block the affinity absorption of GST-SH3Src to AFAP-
110.   This indicates that both MAb 4C3 and F1 recognize AFAP-110’s SH3 binding
motif and, as a consequence, block the interaction between SH3 and AFAP-110.
Alternatively, the binding of either MAb 4C3 or F1 to a distinct epitope within AFAP-
110 may induce a conformational change to alter the structure of SH3 binding motif.
Previous studies showed that amino acids 62-71 are defined as the Src SH3 binding
motif, while the adjacent proline rich motif (amino acids 75-84) is not required for SH3
binding (Guappone and Flynn, 1997).  Site directed mutagenesis and
immunoprecipitation show that F1 reacts with either of two single point mutated forms of
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AFAP-110 (SH3 binding motif, AFAP 71A and the adjacent proline rich motif, AFAP77A)
and double mutant (AFAP71/77A).  This indicates that F1 may either recognize the SH3
binding motif or a distinct epitope, preventing SH3 binding by steric hindrance or by
conformational change upon SH3 binding motif. However, MAb 4C3 is less reactive with
either AFAP71A or AFAP77A,  and not efficiently reactive with the double mutant,
AFAP71/77A.  These data imply MAb 4C3 recognizes an epitope between amino acids 71-
77, and both Pro71 and Pro77 within AFAP-110 are important for immunoreactive with
MAb 4C3 antibody.  Structural predictions and mutagenesis analysis indicate that SH3
binding motif is defined as PEIP71 sequence (Guappone and Flynn, 1997; Ren et al, 1993;
Weng et a, 1994; Cheadle et al, 1994; Rickles et al, 1994;  Sparks et al, 1994), thus Pro71
represents an important residue within the SH3 binding motif and locates at one end of
this motif.  Mutagenesis of Pro77 affects MAb 4C3’s immunoreactivity.  This indicates
MAb 4C3’s epitope includes the SH3 binding motif and the adjacent proline rich
sequence as well.  Because SH3 interactions are important for the formation of
Src527F/AFAP-110, these data may explain why preincubation of AFAP-110 with either
MAb 4C3 or F1can block co-immunoprecipitation of AFAP-110 with Src527F.  It seems
likely that both  MAb 4C3 and F1 selectively bind to AFAP-110 that doesn’t form
complex with Src527F.   There is one amino acid difference between avian and human
isoforms of AFAP-110 in the epitope recognized by MAb 4C3.  This may explain why
MAb 4C3 is unable to react with mammalian isoform of AFAP-110.  The data are useful,
because the epitope recognized by MAb 4C3 may  be used as an internal epitope-tag to
localize and characterize mutants of avian AFAP-110 expressed in mammalian cells.
This is important, because AFAP-110 is a signal protein and this internal epitope may
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help us to identify the mechanism by which AFAP-110 influenzes the integrity of actin
filaments in vivo.
MAb anti-AFAP-110 recognizes an epitope around the carboxy terminal region,
including Lys593.  This is based on the observation that deletion of either leucine zipper
motif (AFAP∆lzip, amino acids 550-593) or the last 44 carboxyl terminal amino acids
(AFAP∆44, amino acids 593-637) will prevent the binding of AFAP-110 by this antibody.
The deletion of last 22 carboxy terminal sequence (AFAP∆22, amino acids 615-637) had
no effect on binding.  The common sequence lacking between AFAP∆lzip and AFAP∆44 is
Lys593.  Therefore, we hypothesize that the epitope for MAb anti-AFAP-110 is defined by
sequence including and flanking Lys593.  This sequence is part of predicted leucine zipper
motif, which is at 5th haptad repeat (Qian et al, 1998).  In addition, MAb anti-AFAP-110
recognizes this epitope across species, indicating that this epitope is conserved among
different species.  Interestingly, this epitope is adjacent to the actin binding domain
(amino acids 600-618).
There is an F1 recognizable 82 kDa polypeptide detected by Western blot analysis
when AFAP-110 is expressed in Cos-1 cells.  It was hypothesized this may be a
proteolytic breakdown product of AFAP-110 (Flynn et al, 1995).  This same size
polypeptide is also detected in CE cells and was hypothesized as a proteolytic breakdown
product of endogenous AFAP-110 (Flynn et al, 1993).  MAb anti-AFAP-110 can not
detect this polypeptide.  Similar observations were found in the neuronal AFAP-120
(Flynn et al, 1993).  AFAP-120 is a neuronal isoform of AFAP-110, and contains an
additional 86 amino acid insertion between Ser510 and Phe511.  This insertion doesn’t
disrupt the downstream reading frame and adds approximately 10 kDa of Mr to AFAP-
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120 compared to AFAP-110.   Western blot analysis with F1 found a 95kDa
immunoreactive polypeptide as for cell lysates expressing AFAP-120.  This 95 kDa
polypeptide is also not immunoreactive with MAb anti-AFAP-110,  similar to 82 kDa
polypeptide.  In addition, AFAP∆84 has similar or slightly increased Mr compared to the
82 kDa proteolytic polypeptide.  Taken together, these data indicate that the 82 kDa
proteolytic breakdown product lacks carboxy terminal sequence of AFAP-110, and the
unidentified proteolytic site may be between Phe511 and Try553.  The proteolytic
breakdown polypeptide should be unable to set on actin filaments same as AFAP∆84
phenotype (Qian et al, 1998).  Therefore, it may provide a regulatory mechanism by
which AFAP-110 is removed from actin filaments.  AFAP-110 has been shown to have
the ability to bind to actin filaments and may have the ability to mediate effects of other
signaling proteins upon actin filaments through its PH domains, SH2 and/or SH3 binding
motifs (Flynn et al, 1993; Guappone and Flynn, 1997; Qian et al, 1998; Guappone et al,
1998; Gibson et al, 1994; Shaw G, 1996).  There are several examples whereby
proteolysis regulates the function of cytoskeleton associated proteins.  Ezrin is one of
these examples, which may affect the motility of epithelial cells by proteolysis (Yao et al,
1993; Shuster and Herman, 1995).  Some integrins can be cleaved by calpain in motile
cells and may be associated with motility via disruption of cell-matrix interactions
(Huttenlocher et al, 1997).  In addition, calpain can cleave some isoforms of protein
kinase C as well as pp125FAK by which the remodeling of actin filaments can be regulated
(Melloni et al, 1985; Cooray et al, 1996; Vuori and Rouslahti, 1993; Lewis et al, 1996).
These proteins are substrates of calpain which preferentially cleaves amino acid
sequences that contain residue with bulky side groups in position 1 (e.g., Arg, Lys, Tyr
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and Met) and a hydrophobic amino acid in position 2 (Croall an Demartino, 1997).
Although there are several sequence sites that could be cut by calpain between amino
acid 511 and 553 of AFAP-110, no evidence has been demonstrated whether AFAP-110
can be digested by calpain either in vivo or in vitro.   Nevertheless, it is possible that
proteolysis may regulate AFAP-110 function.
 In summary, both MAb 4C3 and MAb anti-AFAP-110 will provide useful tools
to study the functional roles of AFAP-110.  MAb 4C3 will provide a useful internal
epitope tag to characterize and localize both normal and different mutant variants of
avian AFAP-110 expressed in mammalian cell lines,  while MAb anti-AFAP-110 will
provide a useful tool to determine the mechanism by which AFAP-110 regulates the
integrity of actin filaments in response to cellular signals.
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TABLE 1   Homolgy of the 75 amino acids of AFAP-110 and Urf- a putative
human homolog of AFAP-110.  The avian AFAP-110 and Urf amino acid sequences are
94%  homologus.   The arrow denotes the single amino acid change in the mAB 4C3
epitope.
Figures and Figure legends
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Figure 1. (A) MAb 4C3 Competitively Blocks SH3 Absorption of AFAP-110 and
AFAP1-145 from Cell Lysates. CE cells were lysed and preincubated with mAb 4C3 (Lane
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2), Ab F1 (Lane 3) or PBS (Lane 4 and 5).  Affinity absorption with GST-SH3src (Lanes
2-4) or GST (Lane 5) followed by western blot analysis. Twenty-five µg of CE cell lysate
was resolved for comparison (Lane 1).  (B) Cell lysates containing AFAP1-145 were
preincubated with mAb 4C3 (Lane 2), Ab F1 (Lane 3) or PBS (Lane 4 and 5).  Affinity
absorption was done with GST-SH3src (Lanes 2-4) or GST (Lane 5). AFAP1-145 was
resolved for comparison (Lane 1). (C) Scanning densitometric analysis of affinity
absorbed AFAP-110, relative to affinity absorption of AFAP-110 by GST-SH3src. The
bar graph demonstrates the average reduction of AFAP-110 affinity absorption in two
experiments upon mAb 4C3 or Ab F1 preincubation.
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Figure 2. Identification of the Epitope Recognized by mAb 4C3. Cos-1 cell
expressing AFAP-110 (Lane 1), AFAP∆71A (Lane 2), AFAP77A (Lane 3), or AFAP71A/77A
(Lane 4) or Cos-1 cells were lysed and 25 µg of lysate resolved by 8% SDS-PAGE. (A)
Western blot analysis was performed with Ab F1, then stripped and reprobed with (B)
mAb 4C3.
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Figure 3. MAb 4C3 Recognizes an Avian-Specific Epitope. C3H10T1/2 murine
fibroblast cells were processed for immunofluorescence localization of endogenous
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AFAP-110 using Ab F1, followed by detection with anti-rabbit antibodies conjugated to
TRITC (Panel A) and FITC-conjugated phalloidin, to highlight actin filaments (Panel B).
C3H10T1/2 cells were transiently transfected with a cDNA encoding avian AFAP-110
and immunofluorescence labeling performed by incubating the cells with either mAb 4C3
followed by anti-mouse antibodies conjugated to TRITC (Panel C) and FITC-conjugated
phalloidin to highlight actin filaments (Panel D).
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Figure 4. (A) The Carboxy Terminus of AFAP-110 Contains a Leucine Zipper
Motif, defined by amino acids 564-598, and an actin binding motif, defined by amino
acids 599-637. (B) Deletion variants of AFAP-110 were generated by engineering in stop
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codons in place of the codons at amino acid positions 615 (AFAP∆22), 593 (AFAP∆44) or
554 (AFAP∆84).  AFAP∆lzip lacks amino acids 559-593. These deletions remove part or all
of the actin binding motif (AFAP∆22 and AFAP∆44, respectively), as well as the leucine
zipper motif (AFAP∆84), or only the leucine zipper motif (AFAP∆lzip). Domain structure:
(A) amino acids 1-61 - unknown function, (B) amino acids 62-71 - SH3 binding motif,
(C) amino acids 75-84 - proline-rich motif, (D) amino acids 85-152 - SH2 binding motif
contain Y94, (E) amino acids 153-248 - pleckstrin homology domain I, (F) amino acids
210-360 - target site for serine/threonine kinases, (G) amino acids 347-450 - pleckstrin
homology domain II, (H) amino acids 450-510 - SH2 binding motif containing Y451/453,
(I) amino acids 511-637 in AFAP-110 carboxy terminal leucine zipper motif and actin
binding domain.
62
Figure 5. MAb anti-AFAP-110 Recognizes an Epitope that Includes Lys593 in the
Leucine Zipper Motif. Cos-1 cell lysates were transfected with AFAP-110 (Lane 1),
AFAP∆84 (Lane 2), AFAP∆44 (Lane 3), AFAP∆22 (Lane 4) and AFAP∆lzip (Lane 5).
Twenty-five µg of cell lysate resolved by 8% SDS-PAGE and transferred to PVDF by
western transfer. (A) Western blot of cell lysates with Ab F1, then stripped and reprobed
with (B) mAb anti-AFAP-110.
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Abstract
AFAP-110 is a tyrosine phosphorylated substrate of Src. It has both SH2 and SH3
binding motifs, and has been hypothesized to link Src to actin filaments and facilitate the
effects of Src upon actin filaments.  But, it is not clear how Src affects both the structure
and function of AFAP-110, or whether AFAP-110 has the ability to modulate the
integrity of actin filaments.  In this report, we found that AFAP-110 has a leucine zipper
motif within its carboxy terminus, indicating AFAP-110 has the potential to self-
associate.  Expression of carboxy terminus of AFAP-110 as a GST-fusion protein
enabled affinity absorption of AFAP-110 from Cos-1 cell lysates that overexpressed
AFAP-110.  The integrity of leucine zipper motif is required for affinity absorption, but
the affinity absorption is not due to a classical leucine zipper motif.  Expression of
Src527F, but not cSrc, abrogates affinity absorption, indicating Src transformation induces
a conformational change in AFAP-110.  Superose chromatography demonstrates that
AFAP-110 exists as either a monomer or multimer (tetramer or trimer) in cell lysates,
indicating AFAP-110 does have the ability to self-association in vivo.  Expression of
Src527F only permit the detection of a singer multimer form of AFAP-110, indicating the
profile of AFAP-110’s self-association is changed upon Src527F transformation, in vivo.
Deletional mutagenesis experiments indicate a regulatory role for the carboxy terminus in
AFAP-110.  Deletion of the entire carboxy terminal long α-helix prevents colocalization
with actin filaments, while deletion of only leucine zipper motif repositions both AFAP-
110∆lzip and actin filaments into rosette like structure, similar to the phenotype of Src527F
transformation.  Therefore, these data indicate that AFAP-110 may play an important role
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in modulating the integrity of actin filaments through a motif that also affects
multimerization.
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Introduction
cSrc is one of non-receptor tyrosine kinases, which is enzymatically maintained in
repressed form in vivo (Cooper and Brown, 1996).  The transient activation of cSrc is
observed during G2/M transition of the cell cycle, indicating the tyrosine kinase activity
of cSrc is tightly controlled and that activation of cSrc is important for cell cycle
progression (Roche et al, 1995; Taylor and shalloway, 1996).  Constitutive activation of
cSrc is sufficient for the transformation of cells in culture.  One characteristic of cSrc
transformation is a change in cell morphology that is linked to the disruption of actin
filaments (Cooper and Brown, 1996; Felice et al, 1990; Reynolds et al, 1989; Flynn et al,
1993).  The transition of G2/M within the cell cycle is marked by the relaxation of actin
filaments, which is prior to the onset of mitosis (Jackson and Bellet, 1989).  Therefore,
one consequence of cSrc transformation may be the disruption of actin filaments, which
in turn affects the phenotype and growth of cells that express activated cSrc.  There is
some evidence that constitutively activated cSrc is observed in some cancer cells (Rosen
et al, 1986; Jacobs and Rubsamen, 1983; Cartwright et al, 1989; Cartwright et al, 1990;
Bolen et al, 1987; Staley et al, 1997), indicating constitutively activated cSrc may
contribute to the formation of the cancer phenotype.  The disruption of actin filaments is
the hallmark of transformation by both vSrc and constitutively activated cSrc (Reynolds
et al, 1989; Felice et al, 1990).  The mechanism whereby activated cSrc affects cell
growth and morphology is unknown.  It is hypothesized that cSrc phosphorylates protein
substrates on tyrosine and, as a consequence, these phosphorylated substrates may
modulate the transfer of cellular signals to influence cell growth and transformation
(Schaller et al, 1993).   It is clear that understanding the mechanism by which activated
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variants of cSrc affect their substrates is important for understanding how non-receptor
tyrosine kinase modulates cellular signals that affect cell growth and transformation.
One model system for understanding the affects of Src upon actin filaments is
AFAP-110 (Actin Filament Associated Protein, 110 kDa; Flynn et al, 1993; Flynn et al,
1995).  AFAP-110 is a tyrosine phosphorylated Src substrate and binding partner.  It was
found that AFAP-110 can form a stable complex with activated variants of Src, and
formation of the stable complex is dependent on the integrity of SH2 and SH3
interactions (Reynolds et al, 1989; Kanner et al, 1991; Flynn et al, 1993; Guappone et al,
submitted).  It has been hypothesized that AFAP-110 may facilitate interactions between
SH2 and/or SH3 containing signal proteins and actin filaments, and facilitate the effects
of these proteins on actin filaments (Flynn et al, 1993).  The consequences of Src and
AFAP-110 interaction are unknown.  It is hypothesized that AFAP-110 may serve to
facilitate the effects of Src upon actin filaments.  Therefore, understanding the function of
AFAP-110 and the effects of Src upon AFAP-110 may provide the clue to the mechanism
by which AFAP-110 is involved in Src mediated signal transduction and, eventually, to
dissect the mechanism by which Src affects cell growth and morphology.
One strategy to characterize the function of AFAP-110 is to identify its domain
structure (Figure 1).  It has one SH3 binding motif, which is shown to facilitate
interactions with Src, Fyn and Lyn (Flynn et al, 1993; Guoppone and Flynn, 1997).   SH3
interaction between Src and AFAP-110 is important to present AFAP-110 for the
phosphorylation (Kanner, et al, 1991; Guoppone and Flynn, 1997).  There is a possible
WW domain binding site adjacent to SH3 binding motif.  AFAP-110 also contains two
SH2 binding motifs and two pleckstrin domains (PH) (Gibson et al, 1994; Shaw, 1996;
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Flynn et al, 1993).  There is a serine/threonine substrate region between two PH domains,
indicating AFAP-110 may be phosphorylated at serine/threonine as well.  Both AFAP-
110’s domain structure and localization within the cells indicate that AFAP-110 may
have the ability to facilitate the interactions between SH2/SH3 containing signal proteins,
and/or other signal proteins, and actin filaments.
Interestingly, there is an isoform of AFAP-110 in brain tissue cells called AFAP-
120 (Flynn et al, 1995).  It encodes additional 86 amino acids, inserted between Ser510
and Phe511, termed novel insert (NINS, Figure 1).  It was found that NINS doesn’t disrupt
the downstream reading frame of carboxy terminal 127 amino acids, which is common
between AFAP-110 and AFAP-120 (Flynn et al, 1995).  This indicates that the carboxy
terminal 127 amino acids may have an important function for both AFAP-110 and
AFAP-120.  This report is designed to address the function of carboxy terminal 127
amino acids in AFAP-110.
Materials and methods
Cell culture in vivo expression and immunofluorescence localization
Cos-1 cells were maintained in DMEM containing 5% fetal calf serum, 2 mM
glutamine and 1% penicillin/streptomycin. Transfection of pCMV-1 plasmid constructs
into Cos-l cells was carried out according to the method of Chen and Okayama, (1987).
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pCMV-1 constructs containing pp60527F and/or AFAP-l 10 were generated as
previously described (Guappone et al., 1996). AFAP∆84 encodes Met1-Tyr553 and lacks
the carboxy  terminal 84 amino acids. AFAP∆84 was created by generating a stop codon
by site-directed mutagenesis. Sequence analysis confirm the presence of this stop codon
and the integrity of flanking sequences. The carboxy terminus was sequenced in its
entirety and subcloned into AFAP-110, to ensure that no spurious mutations could be
present. AFAP-110∆84 was subcloned from pBluescript KS+ into pCMV-1 using the KpnI
and XbaI restriction sites, similar to the cloning of AFAP-110 into pCMV-1 (Guappone
et al., 1996). AFAP∆lzip lacks the leucine zipper motif. Deletion of the leucine zipper
motif was accomplished by generating a second BglII restriction site in the carboxy
terminus by site directed mutagenesis. The mutations did not affect the coding sequence
outside of the deleted leucine zipper motif. The BglII site was engineered at bp 1689
(using the AFAP-110 sequence numbering system -accession number L20303). A second
BglII site exists at bp 1798. Digestion with Bg1II and religation removed bp 1689-1798
and created pCMVAFAP∆lzip, which lacks amino acids 554 - 598. The leucine zipper motif
is defined by amino acids 564-593.
For immunofluorescence analysis, transfected cells were grown on coverslips.
Sixty to 66 h post-transfection, the transfected Cos-1 cells were fixed with 3.7%
formaldehyde, 30 min, 4°C. The cell membranes were permeabilized with 0.1% Triton
X-100, 4min, 21°C. Immunofluorescence localization of transiently expressed AFAP-110
or AFAP110∆84 was accomplished using Ab F1, as previously described (Flynn et al.,
1993). Concentrations of Ab F1 were reduced to 1 µg/µl to preferentially image
transiently expressed proteins and not Cos- I cellular AFAP-110, by immunofluor-
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escence. Ab F1 was detected with donkey a-rabbit TRITC (Sigma). Actin filaments were
imaged using FITC-phalloidin (Sigma). After the final wash, the coverslips were
mounted on slides for image analysis. Immunofluorescence images for actin filaments,
AFAP-110, AFAP∆84 and AFAP∆lzip were acquired and analyzed in the WVU Anatomy
department Image Analysis Lab using a Zeiss confocal microscope and scanning
different planes of the cell. Images presented reflect single scanned planes. The images
were collected as color and reprocessed for black and white.
Generation of GST encoded fusion proteins and affinity absorption
pGex-cterm was created by PCR amplification (with engineered BamHI and
EcoRI restriction sites at the end of each primer) of the coding sequence in AFAP-110
encoding Phe511 to Asp637 and was subcloned into the novel BamHI and EcoRI sites in
pGex-2T. Similarly, deletion variants of the GST-cterm were created by PCR amplifica-
tion of the specified region and subcloned into pGex-2T via the unique BamHI and
EcoRI sites. Deletion of the leucine zipper motif in pGex-cterm was accomplished by
engineering a Bg1II site at bp 1689-1693 (using the AFAP-110 sequence numbering
system -accession number L20303) in pGEX-cterrn. Creation of this new BglII site
required site-directed mutagenesis of bp 1689 from G→A and at bp 1680 A→G. A
second BglII site exists at bp 1798. Digestion with BglII and religation removed bp 1689-
1798, which removes amino acids 558-593. All constructs were verified by sequence
analysis over the amplified region. The preparation of bacterial lysates containing these
fusion proteins as well as immobilization of the fusion proteins to glutathione-coated
sepharose beads, was accomplished as previously described (Guappone et al., 1996). All
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immobilized fusion proteins were quantitated before absorption by resolving the
immobilized protein on a 12% SDS-PAGE and quantitating by Coomassie staining.
Twenty µg of fusion protein was immobilized upon 100 µg glutathione-coated sepharose
beads (50% slurry, Pharmacia). Cell lysates were prepared with NP40 lysis buffer (1%
NP-40; 50 mM Tris, pH 7.5; 150 mM NaCl; 2 mM Sodium Vanadate; 2 mM PMSF;
50µg/ml aprotinin; 2 mM EGTA). Lysis buffers containing ionic detergents, e.g., RIPA
containing SDS and/or 0.25% deoxycholate, did not permit efficient and reproducible
affinity absorption (data not shown).
Immobilized fusion proteins were incubated with 100µg Cos-1 cell lysates (0.2
µg/µl) for I h, 4°C, while rotating on an orbital shaker. Immobilized cellular proteins
were washed twice with NP-40 lysis buffer (200 A) and twice with trisbuffered saline
(200 µl; 50 mM tris, pH 7.5; 150 mM NaCl) then eluted by adding 50 µl 2 x Laemmli
sample buffer and boiling for 3-5 min. The solubilized proteins were separated from the
sepharose beads by centrifugation, and resolved by SDS -PAGE, as previously described
(Guappone et al., 1997; Flynn et al., 1995).
FPLC analysis and gel filtration
Gel filtration of Cos-1 cellular lysates was accomplished using a Superose 6 10/30
chromatography column and FPLC. The column was equilibrated with 1% NP40 lysis
buffer and molecular weight standards were run independently of each other, using
dimeric Jack Bean Urease, Alcohol dehydrogenase, dimeric BSA, ovalbumin, dimeric
carbouic anhydrase and β-amylase as standards. One hundred µl of transfected Cos-I
cellular lysates was injected into the column. This represents approximately 1/10th of the
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total cell lysate obtained from a 100 mm plate (approximately 100 µg of total cellular
protein lysate ). Fractions were collected every 2 min (0.4 ml/fraction with a flow rate of
0.2 ml/min), beginning after 12 mls of buffer had been eluted through the column.
One-hundred µl from each fraction were resolved by 8% SDS-PAGE and probed for the
presence of AFAP-I 10 by Western blot analysis with Ab Fl.
Protein characterization and analysis
The monoclonal antibody 4C3 (Kanner et al., 1989) was used as previously
described (Kanner et al., 1990) and the polyvalent antibody (Ab) FI was prepared as
previously described (Flynn et al., 1993). Isolation of immune complexes, Western
transfer and Western blot analysis with Ab F1 were done as previously described (Flynn
et al., 1993). Bound primary antibody was quantitated using an HRP-conjugated
secondary antibody followed by detection using chemiluminescence.
Results
The carboxy terminus of AFAP-110 contains a leucine zipper motif.
AFAP-120 is a variant form of AFAP-110, and encodes an additional 256 bp
sequence that is predicted to encode 86 amino acids, referred to as a novel insert (NINS)
(Flynn et al, 1995).   Because NINS doesn’t disrupt the downstream reading frame of
carboxy terminal 127 amino acids that are conserved between AFAP-110 and AFAP-120
(Figure 1), we projected that the carboxy terminal 127 amino acids may have some
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important functions.  A homology search found that there are two classes of proteins:
cytoskeleton proteins and transcriptional factors, which have homologous domain as the
carboxy terminus of AFAP-110 (Table 1). The detailed study found that homologous
domain is located between amino acids 553 and  593 and may exist as a heptad repeat
called leucine zipper motif.  The leucine zipper motif is a well known protein interaction
domain structure in transcription factors as well as cytoskeleton proteins (Hurst, 1994;
Busch and Sassone-Vorsi, 1990).  Sequence analysis found there is no basic region
upstream the leucine zipper motif of AFAP-110, indicating that AFAP-110’s leucine
zipper may not be able to bind to DNA (data not shown).
Affinity absorption of AFAP-110 from cell lysates with a GST-encoded fusion
protein expressing the carboxy terminal 127 amino acid fragment
The leucine zipper motif is a well-characterized domain structure, which mediates
protein-protein interaction (Busch and Sassone-Corsi, 1990).  Many leucine zipper
containing proteins are able to self-associate. The homology data implies that AFAP-110
may have the ability to associate with itself or other proteins through its carboxy terminal
127 amino acids.  To determine whether AFAP-110 has the ability to self-associate, the
affinity absorption experiments were applied.  We used GST fusion protein that expresses
carboxy terminal AFAP-110 (GST-cterm) to affinity absorb cellular AFAP-110, which
was over-expressed in Cos-1 cells.  The secondary structure of the carboxy terminus of
AFAP-110 was evaluated.  It was shown that the first 42 amino acids of the carboxy
terminus exist as a combination of coil, β-sheath and turn, referred as coil/turn region
(Figure 2a).  The carboxy 84 amino acids is predicted to be a single long α-helical
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structure, and the leucine zipper motif in part of this long α-helix, located at the amino
terminus of this α-helix (Figure 2a).  Four deletion variants of GST-cterm were created to
determine which region within carboxy terminus is important for self-association (Figure
2a).  All of the fusion proteins were immobilized on glutathione-coated sepharose beads,
and used to absorb Cos-1 cell lysates overexpressing AFAP-110.  The data showed GST-
cterm, GST-CT∆42 and GST-CT∆44 were able to affinity absorb cellular AFAP-110 while
GST alone was unable to affinity absorb AFAP-110 (Figure 2b).  There is a slight
decrease in affinity absorption of GST-CT∆42 and a slight increase in affinity absorption
for GST-CT∆44, indicating a structural or regulatory role for these regions in affinity
absorption.  There is also an 82 kDa band below AFAP-110, and we hypothesized it was
an AFAP-110’s proteolytic breakdown product (Flynn  et al, 1995; Qian et al, 1999).
GST-CT∆Lzip was deficient in binding of cellular AFAP-110 while GST-CT∆84 was
unable to bind to cellular AFAP-110 altogether (Figure 2b).  These data indicate the long
α-helical structure including leucine zipper motif is important for affinity absorption of
AFAP-110.  Therefore, AFAP-110 may have the ability to self-associate through carboxy
terminal interaction, and the long α-helical region is required for the interaction.
Leucine zipper motifs mediate protein-protein interactions by forming a
hydrophobic interaction  with other similar or identical leucine zipper motifs (Busch and
Sassone-Vorsi, 1990).  To determine whether affinity absorption is mediated by the
hydrophobic interactions defined by a classic leucine zipper interaction, or by other
interactions defined in the α-helix, point mutations were targeted within the integral part
of the leucine zipper.  Leu581 is the third leucine within the heptad repeat and this leucine
was mutated to Pro within GST-cterm (GST-CTL581P).  This mutation is predicted to
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create a short turn in the α-helical region.  Leu574 is the second  leucine within the heptad
repeat and this leucine was mutated to Arg.  This mutation was predicted to disrupt the
hydrophobic interaction that normally mediated by leucine zipper residues.  The second
leucine mutation was introduced into GST-CTL581P (GST-CTL574R/L581P).  The affinity
absorption using both normal and mutated GST-cterms show that GST-cterm, GST-
CTL581P and GST-CTL574R/L581P each can affinity absorb cellular AFAP-110 (Figure 2c).
These data indicate that affinity absorption of AFAP-110 is not mediated by hydrophobic
interactions defined by the classic leucine zipper motif, and might be mediated by a
distinct interaction within the carboxy terminal α- helix instead.
Co-expression of Src527F, but not cSrc, prevent GST-cterm from absorbing AFAP-
110 from Cos-1 cell lysates.
To determine how the putative AFAP-110’s self-association is regulated in vivo,
the affinity absorption was performed using AFAP-110, co-expressed either with
enzymatically activated Src527F or enzymatically inactivated cSrc, to evaluate the effects
of Src on the ability of GST-cterm to absorb cellular AFAP-110.  AFAP-110 was
transiently expressed in Cos-1 cells alone, co-expressed with either Src527F or cSrc
(Figure 3), as previously described (Guappone et al, 1996).  The expressed AFAP-110s
were immunoprecipitated with F1 antibody and the level of tyrosine phosphorylation was
quantitated using rabbit anti-phosphotyrosine.  The data show there are equal amounts of
AFAP-110 immunoprecipitated from Cos-1 cell lysates, expressing AFAP-110 alone,
coexpressing with Src527F and coexpressing with cSrc (Figure 3a).  Both Src527F and cSrc
can phosphorylate AFAP-110 to significantly high levels while expression of AFAP-110
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is not tyrosine phosphorylated in the absent of Src (Figure 3b).  Affinity absorption show
GST-cterm can affinity absorb both AFAP-110 expressed alone and AFAP-110
coexpressed with cSrc, but it is unable to absorb AFAP-110 coexpressing with Src527F
(Figure 3c).  The abrogation of the affinity absorption may not be due to tyrosine
phosphorylation, as both cSrc and Src527F can phosphorylate AFAP-110 on tyrosines
(Figure 3b), and GST-cterm can affinity absorb tyrosine phosphorylated AFAP-110 that
coexpresses with cSrc (Figure 3d).  These data indicate that enzymatically activated
Src527F might direct a molecular event that disrupts the interaction between GST-cterm
and AFAP-110.  It is possible that this molecular event is independent of tyrosine
phosphorylation.   Alternatively, Src527F may phosphorylate some tyrosine residues that
are not phosphorylated by cSrc, and these Src527F phosphorylated tyrosines may modulate
some structure changes within AFAP-110 to prevent affinity absorption by GST-cterm.
AFAP-110 can exist as a monomer or multimer in cell lysates
The affinity absorption of AFAP-110 by GST-cterm indicates that AFAP-110
may have the ability to self-associate, in vivo.  To test this possibility, Cos-1 cell lysates
expressing AFAP-110 were resolved by gel filtration. We used FPLC and a Superose 6
10/30 column to collect fractions of cell lysates.  Superose 6 10/30 column has the
capability to resolve protein complexes between 29 kDa and 500 kDa.  The predicted size
of AFAP-110 is 72,315 Da and its relative mobility (Mr) on SDS-PAGE is 110 kDa
(Flynn et al, 1995). Therefore, the Superose 6 10/30 column can identify AFAP-110
multimeric complexes, in vivo.  Nineteen 400 µl fractions were collected and 100 µl of
each was resolved on 8% SDS-PAGE (Figure 4a).  Western blot was applied to detect
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AFAP-110 using F1 antibody.  The data show that AFAP-110 can be detected in two
major peaks defined as fractions 7-12 and 16-18, and the Mr of AFAP-110 appears as
doublet bands (Figure 4a, lanes 7-12, 16-18).  Scanning densitometry was used to
quantitate the resolved fractions (Figure 4d), and it shows there are at least two, possibly
three, peaks of distribution of AFAP-110.  The first peak predicates a multimeric
population of AFAP-110 around 410 to 150 kDa represented by fraction 7-12 while
second peak is around 250 kDa represented by fraction 8-9.
These peaks predict AFAP-110 exists as a monomer to tetramer complexes in cell
lysates, with fractions 9 and 10 predicting a tetramer.  Fractions 11 and 12 appear as a
shoulder adjacent to the tetrameric peak.  Interestingly, there is a distinct peak from
fractions 16 to 18.  The predicted size for this peak is around 70 to 42 kDa, indicating a
monomeric population, in vivo.   The peak shown at fraction 14 is likely artifact (Figure
4d), and appears as an unknown shadow shown by western blot and was read by scanning
densitometry (Figure 4b).  Lastly, there is very little detectable endogenous AFAP-110 in
Cos-1 cell lysates (data not shown).  These data indicate AFAP-110 does have the ability
to self-associate in NP-40 cell lysates overexpressing AFAP-110.
Gel filtration of Cos-1 cell lysates coexpressing AFAP-110 with Src527F shows a
different profile (Figure 4b).  There is one peak between fractions 8-12 that represents Mr
of 340-150 kDa (Figure 4b).  The monomeric AFAP-110 peak is gone.  The Mr of AFAP-
110 is shifted.  Fraction 19 from gel filtration of AFAP-110 is resolved on the lane
marked ∗∗ (Figure 4b).  The size of AFAP-110 is slightly retarded and there is no doublet
band when AFAP-110 is coexpressed with Src527F.  The retarded Mr may represent a
change of post-translational modification after expressing with Src527F.  Stripping and
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reprobing of this western blot with monoclonal antibody to Src527F show Src527F exists in
fraction 10 (Figure 4c).  The predicted size for fraction 10 is 240 kDa (Figure 4d) and the
Mr of a single AFAP-110/Src527F complex is 130 kDa.  Therefore, it indicates that there
may be two molecules of AFAP-110 and two molecules of Src527F, or three molecules of
AFAP-110 and one molecule of Src527F within this 240 kDa fraction.  It is also possible
that the association of Src527F with AFAP-110 may mask a population of AFAP-110 that
exists as tetramers that are not bound to Src527F and elute coincident with fractions 8-12.
The data indicate coexpression of AFAP-110 with Src527F changes the profile of AFAP-
110 in cell lysates and the monomeric AFAP-110 is significantly reduced.
The integrity of the carboxy terminal α-helix influences cellular localization of
AFAP-110
Experiments were designed to test the effects of the integrity of carboxy terminal
α-helical domain on AFAP-110’s subcellular localization.  Two deletion mutant variants
were created.  AFAP∆84 lacks the entire carboxy terminal α-helical region, while
AFAP∆lzip has no leucine zipper motif (one-half this α-helix).  AFAP-110, AFAP∆84 and
AFAP∆lzip were transiently transfected into Cos-1 cells (Figure 5), to determine the
functional role of the carboxy terminal α-helical region in AFAP-110’s subcellular
localization.  Either AFAP-110 was expressed alone (Figure 6a and 6b) in Cos-1 cells, or
AFAP-110 was coexpressed with either Src527F (Figure 6c and 6d)or cSrc (Figure 6e and
6f).  The data show that AFAP-110 colocalizes with both actin filaments and cell
membrane when it is expressed alone in Cos-1 cells (Figure 6a and 6b), or cSrc (Figure
6c –6fb), and when it is coexpressed with Src527F, the actin filaments are disrupted and
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repositioned into rosette-like structure, same as earlier finding in CE cells (Flynn et al,
1993). Compared to Src527F, the effects of cSrc on actin filaments was much weaker, both
the number and size of rosette-like structure were smaller and fewer.  The deletion
variant AFAP∆84 is unable to colocalize with either actin filaments or cell membrane
(Figure 6g and 6h)).  It is located in the cytoplasm and exhibited in diffuse staining
pattern.  The data indicate that the carboxy terminal α-helical domain is important for
both AFAP-110’s colocalization with actin filaments and the cell membrane.
Interestingly, deletion of only the leucine zipper motif region (AFAP∆lzip) resulted in the
redistribution of both AFAP∆lzip and actin filaments into rosette-like structures (Figure 6i
and 6j).   These data indicate that the carboxy terminal α-helical region is important for
AFAP-110’s association with actin filaments and cell membrane, and the removal of
leucine zipper motif will induce a change of integrity of actin filaments similar to the
effects of Src527F transformation.
Discussion
AFAP-110 has a leucine zipper motif in its carboxy terminus, implying that
AFAP-110 may have the potential to self-associate through this region, in vivo.  The
experiments in this report addressed whether AFAP-110 had the ability to self-associate
through the carboxy terminus and whether Src regulated AFAP-110’s self-association,
such that we can understand the role of the leucine zipper motif in AFAP-110.  Cellular
AFAP-110 can be affinity absorbed by GST-cterm fusion protein, indicating AFAP-110
may have the ability to self-associate.  Deletion of the carboxy terminal 84 amino acids
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from GST-cterm abrogates this affinity absorption, indicating the carboxy terminal
domain has enough sequence to mediate AFAP-110’s self-association.  Our data show
the affinity absorption is not mediated by a classical leucine zipper interaction.  Leucine
zipper motifs are a well-characterized protein domain involved in both homedimerization
and hetrodimerization in different kinds of cellular proteins, including transcription
factors (Hurst, 1994), cellular kinases (Ruth et al, 1997; Gamm et al, 1995; Kitigawa et
al, 1995), transmembrane receptors (Saras et al, 1994; Kein et al, 1993; Rodrigues an
Park, 1993; Chen et al, 1993) and cytoskeletal proteins (Klein et al, 1993; Bikle et al,
1996; Pearlman et al, 1994; Ward an Kirshner, 1990; Maekawa and Kuriyama, 1993).
The mechanism by which the leucine zipper motif mediated dimerization is mainly
through a hydrophobic interaction between two heptad repeat monomers (Hodges, 1996).
Our data show that mutation of either one leucine residue (Leu→Pro) or two leucine
residues (Leu →Arg; Leu→Pro) within GST-cterm do not disrupt its affinity absorption
with AFAP-110.  Mutation of leucine to Proline is predicted to create a turn structure at
third leucine residue within the heptad repeat, while mutation of leucine to arginine is
predicted to disrupt the hydrophobic interaction at second leucine residue within the
heptad repeat.  Therefore, the data indicate the affinity absorption is not likely mediated
by a classical leucine zipper motif in AFAP-110.  It should be noted that other motifs
within the carboxy terminus of AFAP-110 may also contribute to affinity absorption.
Although the coil/turn region (amino acids 511 to 553) doesn’t permit GST-CT∆84 to
affinity absorb cellular AFAP-110, GST-CT∆42, which lacks the coil/turn region has a
slightly reduced ability to bind AFAP-110.  Therefore, the coil/turn region may also
facilitate the binding of GST-cterm to AFAP-110.  GST-CT∆lzip is capable of weakly
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binding AFAP-110, indicating the last 44 amino acids of AFAP-110 (594 to 637) could
contribute the affinity absorption.   It is noteworthy that the carboxy terminus of AFAP-
110 has a net charge of +10, and the leucine zipper region contributes most of this
positive charge (+8).  It is possible that charge repulsion could destabilize multimers
enough to permit affinity absorption, and the removal of this region (leucine zipper
region) may stabilize either GST-cterm multimer or AFAP-110 multimer to impede the
affinity absorption.  Therefore it will be important to determine 1) where are the exact
amino acids that bind GST-cterm; 2) where the opposite binding site is and 3) the
functional role of the leucine zipper motif in the affinity absorption.
GST-cterm is unable to affinity absorb cellular AFAP-110 coexpressed with
Src527F.  We cloned both AFAP-110 and Src527F into the same pCMV vector and place
them under different promoters.  This system enables us to generate high yields of both
AFAP-110 and Src527F, and to generate tyrosine phosphorylated AFAP-110  (Flynn et al,
1993; Guappone et al, 1996; Guappone and Flynn, 1997).  The fact that GST-cterm is
unable to absorb AFAP-110 coexpressed with Src527F indicates that Src527F kinase may
modulate some molecular events to alter the structure of the carboxy terminus and
impede affinity absorption.  The molecular mechanism is unclear, but there are three
possibilities: 1) AFAP-110 is tyrosine phosphorylated by Src527F, which may alter the
structure.  GST-cterm is able to affinity absorb AFAP-110 coexpressed cSrc. It is
possible that Src527F may phosphorylate one or more specific tyrosines that are not
phosphorylated by cSrc, which may contribute to abrogating the affinity absorption.  2)
The formation of the stable complex between Src527F and AFAP-110 may sterilely block
affinity absorption.  Mutated forms of either Src527F or AFAP-110 that fail to form a
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stable complex should provide some clues. 3) Src527F may activate a second protein or
molecule that affects AFAP-110’s structure and prevent the affinity absorption.  One
possible mechanism is Ser/Thr phosphorylation.  Earlier data showed that both Src527F
and vSrc can activate some Ser/Thr kinases (Blenis and Ericson, 1985; Blenis et al, 1987;
Sturgill et al, 1988; Morrison, 1988; Spangler et al, 1989; Nori et al, 1990; Qureshi et al,
1991; Sternberg et al, 1993).  As for AFAP-110, it has a Ser/Thr substrate region and
demonstrates increased levels of Ser/Thr phosphorylation in the presence of Src527F
(Flynn et al, 1993; Kanner et al, 1991)  Experiments are in progress to uncover the
mechanism by which Src527F abrogates the affinity absorption of AFAP-110 by GST-
cterm.
Affinity absorption in vitro predict AFAP-110 may have the ability to self-
association in vivo.  Gel filtration of AFAP-110 overexpressed in Cos-1 cells confirms
that it can be detected in fractions that predict either a multimer or monomer.  The Mr of
AFAP-110 is 72,315Da, and the peak from FPLC that indicates AFAP-110 as a monomer
is predicted as 70-45 kDa.  The slightly retarded Mr of AFAP-110 from FPLC may be
due to the different shape of AFAP-110 and the way it was resolved in FPLC column or
post translational modification.  AFAP-110 is also predicted to exist as a multimer
forming a trimer or tetramer in FPLC fractions.  One possibility is that other cellular
proteins from Cos-1 cells may also join with AFAP-110 complexes in NP-40 treated Cos-
1 cell lysates.  It should be pointed out that AFAP-110 is overexpressed in these Cos-1
cell lysates and AFAP-110 is supposed to be overexpressed  to very high levels per
transfected Cos-1 cell (Guappone et al, 1996; Guappone and Flynn, 1997).  Therefore, we
think the majority of these complexes are AFAP-110, and other cellular proteins may not
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be expressed at high enough levels to change the Mr of these complexes.   These data
indicate that AFAP-110 may have the ability to self-associate and form mutimeric
complexes in vivo.  Identification of the amino acids that are involving in mediating self-
association and affinity absorption is in progress.
When AFAP-110 is coexpressed with Src527F in Cos-1 cells, it is only be detected
in a single peak by gel filtration, which predicts a multirmer with a Mr around 350-150
kDa.  There is no monomeric fraction resolved by gel filtration.  The data indicate
coexpression of Src527F induces AFAP-110 to exist in one fraction.  Src527F is also found
in AFAP-110 multimeric fraction 10 in FPLC.  As Src527F can form a stable complex with
AFAP-110, it is possible that AFAP-110/Src527F complex is formed by either two
molecules of AFAP-110 and two molecules of Src527F or three molecules of AFAP-110
and one molecule of Src527F.  It is unlikely that one molecule of AFAP-110 and three
molecules of Src527F compose the complex.  The earlier data show that one molecule of
AFAP-110 can only bind to one or two molecules of Src527F(Guappone and Flynn, 1997;
Guappone et al, 1998).   It should be point out that the peak resolved by FPLC may reveal
a subpopulation of AFAP-110 that is self-associated and is not in stable complex with
Src527F.  This subpopulation of AFAP-110 would be predicted to exist as a tetramer and
may be resolved coincident with AFAP-110/Src527F complex.  Therefore, the data show
that coexpression of Src527F changes the profile of AFAP-110 in two ways: 1) No
monomer population of AFAP-110 can be detected and  2) AFAP-110 is resolved in a
single band and has a slightly retarded Mr.  These data indicate that Src527F/AFAP-110
complex may result in either 1) Src527F may preferentially bind to monomeric AFAP-110
and then induce Src527F bound monomeric AFAP-110 to multerize or 2) Src527F may
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disrupt the large multimer of AFAP-110 so that the AFAP-110/Src527F complex can be
composed with either two molecules of AFAP-110 and two molecules of Src527F or three
molecules of AFAP-110 and one molecule of Src527F.  As for the retarded Mr of AFAP-
110 in FPLC, it should be point out that there is no molecular weight change in Fig 3a.  It
may be due to the amount of AFAP-110 resolved on the gel or the minor difference in gel
conditions.  The earlier data show that the Mr of Src527F coexpressed AFAP-110 is
changed, but in a less apparent way, when significantly higher amounts of AFAP-110 are
resolved on 8% SDS-PAGE (Flynn, unpublished data).
Most significantly, our data show the integrity of carboxy terminal α-helical
region of AFAP-110 is important for both AFAP-110 and actin filament association, in
vivo, indicating there are some biological functions for the carboxy terminal region.  The
earlier data showed AFAP-110 colocalized with actin filaments when it was expressed in
CE cells, and coexpresson of AFAP-110 with Src527F in CE cells repositioned both
AFAP-110 and actin filaments into rosette like structure, which is concomitant with
Src527F transformation (Flynn et al, 1993).  In this report, we found similar results in Cos-
1 cells.   AFAP-110 is colocalized with actin filaments when it is expressed alone in Cos-
1 cells, and coexpression of Src527F repositions both AFAP-110 and actin filaments into
rosette like structure.  cSrc has no significant effects on actin filaments in either CE cells
or Cos-1 cells, and AFAP-110 maintains colocalizaion with actin filaments in the
presence of cSrc (Reynolds et al, 1989).  Our data also showed the association of AFAP-
110 on either actin filaments or cell membrane are dependent on the integrity of carboxy
terminal α-helical region.  AFAP∆84 is expressed in a diffuse pattern when its carboxy
terminal α-helical region is deleted, and is unable to localize with either actin filaments
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or cell membrane.  Interestingly, deletion of only the leucine zipper motif will permit
AFAP∆lzip to localize on either actin filaments or cell membrane, but both actin filaments
and AFAP∆lzip are repositioned into rosette like structure, similar to the effects on Src527F
on AFAP-110 and actin filaments.
Our data show that deletion of the carboxy terminal 84 amino acids (α-helix
region) doesn’t permit AFAP-110 to colocalize with actin filaments while deletion of
only leucine zipper motif allow AFAP-110 to retain actin filament localization.  The data
indicate the last 44 amino acids of carboxy terminal α-helix region are important for the
actin filament association.  Experiments are in progress to localize actin binding domains
within this region using deletion mutants.  The deletion of the leucine zipper motif
(AFAP∆lzip) repositions both AFAP∆lzip and actin filaments into rosette like structure,
similar to the effects of Src527F on actin filaments and AFAP-110 in either Cos-1 cells or
CE cells (Reynolds et al, 1989; Flynn et al, 1993).  The data indicate AFAP-110 may be
important in modulating the molecular events of Src527F upon the integrity of actin
filaments, and the integrity of leucine zipper motif is central to this role.  We think it is
possible that effects of Src527F to disrupt actin filaments are in part mediated by the
signals that target the structure and function of carboxy terminal α-helical region of
AFAP-110.
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Tables
Table 1   Alignment of AFAP-110 carboxy teminus with other know zipper
containing proteins.
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Figures and Figure Legends
Figure 1  Domain structure of AFAP-120 and AFAP-110.  AFAP-110 contains
637 amino acids.  AFAP-120 contains 723 amino acids.  (a) amino acids 1-61-unknown
function, (b) amino acids 62-71-SH3 binding motif I for Src, Fyn and Lyn, (c) amino
acids 75-84-SH3 binding motif II, (d) amino acids 85-152- putative SH2 binding motif,
(e) amino acids 153-248-pleckstrin homology domain I, (f) amino acids 210-360-target
site for serine/threonine kinases, (g) amino acids 347-450-pleckstrin homology domain II,
(h) amino acids 450-510-potential SH2 binding motif, (I) amino acids 511-637 in AFAP-
110 or amino acids 597-723 in AFAP-120-carboxy terminal leucine zipper motif, (j)
amino acids 511-596 in AFAP-120-Novel Insert in AFAP-120.
94
95
Figure 2  The carboxy terminus of AFAP-110 can modulate dimer formation.  (a)
The carboxy terminus is comprised of two distinct secondary structures.  Amino acids
511-553 predict a region of coils and turns, while amino acids 554-637 predict a α-helix
(I).  Positioned at the amino terminal half of the α-helix is the leucine zipper motif (lzip).
Fusion proteins used for affinity absorption were designed based upon the secondary
structure.  Sequences encoding polypeptides represented in the carboxy terminus of
AFAP-110 were amplified by PCR and subcloned into pGEX-2T, (II) GST-cterm
expresses amino acids 511-637 of AFAP-110, (III) GST-CT∆42 expresses amino acids
553-637, (IV) GST-CT∆44 expresses amino acids 511-593, (V) GST-CT∆lzip contains a
deletion that removes amino acids 554-592, including the majority of leucine zipper
motif which is defined by amino acids 564-598 and (VI) GST-CT∆84 expresses amino
acids 511-553.  (b) Affinity absorption from Cos-1 cell lysates overexpressing AFAP-
110.  AFAP-110 was overexpressed in Cos-1 cells and affinity absorbed with the GST-
encoded fusion proteins, as indicated in lanes 2-7. Lane 1, 25 µg cell lysate
overexpressing AFAP-110 was resolved for comparison.  Proteins were resolved by 8%
SDS-PAGE and Western blot analysis was carried out with mAb 4C3.  Del refers to ∆ or
deletion.  (C) Affinity absorption of AFAP-110 does not occur through a classical leucine
zipper interaction.  Site-directed mutagenesis was employed to mutate one or two leucine
residues to an arginine and/or a proline residue within GST-cterm.  AFAP-110 was
overexpressed in Cos-1 cells and the lysates divided into equal parts for affinity
absorption with GST-cterm or the mutated GST-cterm constructs.  Absorbed AFAP-110
was analyzed by Western blot with mAb 4C3.
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Figure 3  GST-cterm is unable to affinity absorb AFAP-110 co-expressed with
Src527F.  Protein levels and affinity absorption were done using Cos-1 cell lysates
overexpressing AFAP-110.  (a) AFAP-110 was immunoprecipitated with mAb 4C3 and
quantitated by Western bot analysis with AbF1.  (b) Mab 4C3 immunoprecipitation was
stripped and reprobed with rabbit anti-phosphotyrosine.  (c) Affinity absorption of
AFAP-110 with GST-cterm, followed by Western blot analysis with mAb 4C3.  (d)
Affinity absorption of AFAP-110 with GST-cterm was stripped and reprobed with rabbit
anti-phosphotyrosine.
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Figure 4  Gel filtration of AFAP-110 from Cos-1 cell lysates.  One hundred µg of
Cos-1 cell lysates expressing AFAP-110, AFAP-110 and Src527F or AFAP-110 and cSrc,
were resolved by a Supreose chromatography 610/30 column an fractions collected for
Western blot analysis.  (a) Ab F1 Western blot analysis AFAP-110 from Cos-1 cellular
lysate fraction 1-18.  (b) Ab F1 Western blot analysis of Cos-1 cellular lysate fraction 1-
19 for Src527F/AFAP-110, ** indicates fraction #19 from AFAP-110 expressed alone, as a
marker for an AFAP-110 doublet.  (c) Strip and reprobe of fraction #10-12 by Western
blot analysis with mAb EC10, from Cos-1 cell lysates expressing Src527F and AFAP-110.
(d) Scanning densitometry of peak fractions for AFAP-110 from fractions 1-18 (solid line
with diamonds), and Src527F/AFAP-110 (dashed line with squares) from fractions 1-19.
Relative scanning densitometric numbers were normalized to the peak fraction
densitometry number (i.e., the darkest band from each analysis).  Fractionation of
molecular weight (MW) standards are shown in kDa beneath the fraction where eluted.
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Figure 5  Mr of AFAP-110, AFAP∆lzip and AFAP∆84.  Twenty-five µg of Cos-1
cell lysates overexpressing AFAP-110, AFAP∆lzip, AFAP∆84 and Cos-1 lysates were
resolved as indicated by a (+) symbol beneath the appropriate lane.  A (-) symbol
indicates that construct is not expressed in that sample.  Cell lysates were resolved by 8%
SDS-PAGE and Western blot analysis was done using Ab F1.
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Figure 6   Immunofluorescence localization of AFAP-110 and actin filaments in
Coos-1 cells.  Cos-1 cells overexpressing AFAP-110 (a and b), AFAP-110 and Src527F (c
and d), AFAP-110 and cSrc (e and f), AFAP∆84 (g and h) or AFAP∆lzip (i and j) were
analyzed for localization of AFAP-110 (a, c, e, g, I) or for actin filament integrity (b, d, f,
h, j).  Overexpressed AFAP-110 was analyzed using Ab F1 and donkey anti-rabbit
antibodies conjugated to Texas Red (Sigma).   Actin filaments were visualized with
FITC-conjugated phalloidin (Sigma).  Images were acquired using a Zeiss confocal
microscope and represent a single plane of scanning.
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Abstract
The SH2/SH3 binding partner AFAP-110 is both a Src substrate and an actin
binding protein.   It contains several protein binding domains, including a SH2 binding
motif, two SH3 binding motifs, two PH domains and a leucine zipper motif.  The domain
structure indicates AFAP-110 may function as a docking protein to link different
signaling proteins to actin filaments.  Deletion of the leucine zipper motif within the
carboxy terminus of AFAP-110 alters the integrity of actin filaments in Cos-1 cells,
indicating AFAP-110 may have an intrinsic ability to modulate the integrity of actin
filaments.  In this report, we sought to determine whether AFAP-110 could bind to actin
filaments directly.  Analysis of the carboxy terminus of AFAP-110 revealed two
consensus sequences homologous to known actin binding domains.  In vivo and in vitro
experiments showed the carboxy terminus of AFAP-110 directly bound actin filaments,
and the amino acid sequences that are involved in direct actin filament binding were
located between amino acids 593-637, where two homologous actin binding domains
identified.  Importantly, deletion of the leucine zipper motif within the carboxy terminus
of AFAP-110 enables AFAP-110 to alter actin filament integrity and to change cell
shape, characterized by the induction of lamellipodia in both C3H10T1/2 cells and NIH
3T3 cells.  These data indicate AFAP-110 may have an intrinsic ability to alter the
integrity of actin filaments through carboxy terminal interactions.  Thus, we hypothesize
that AFAP-110 may directly bind actin filaments and is positioned to affect actin
filaments in response to interactions with different cellular signaling proteins.
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Introduction
The nonreceptor tyrosine kinase pp60Src (Src) is a prototype member of the Src
family and has been used as a model to study cell signal transduction and cell
transformation (Cooper and Brown, 1996; Pawsons and Weber, 1989).  One of hallmarks
of Src transformation is the disruption of actin filaments.  The mechanism by which Src
affects the integrity of actin filaments is unknown.  One candidate effector protein that
may mediate the effects of Src upon actin filaments is the Src SH2/SH3 binding partner
AFAP-110 (Flynn et al, 1993).  The actin filament associated protein AFAP-110 is a
tyrosine phosphorylated substrate of activated Src (Src527F).  It forms a stable complex
with active Src in primary cultures of chick embryo fibroblast (CE) cells and rat lung
embryo fibroblast cells (Flynn et at, 1993; Liu et al, 1996).  The formation of stable
complex is dependent on both SH2 and SH3 interactions (Reynolds et al, 1989; Kanner et
al, 1991; Guappone and Flynn, 1997).  AFAP-110 has several protein binding domains,
including a SH3 binding motif, two SH2 binding motifs, two pleckstrin homology (PH)
domains, a serine/threonine substrate region at its amino terminus and a leucine zipper
motif at its carboxy terminus (Flynn et al, 1993; Guappone and Flynn, 1997; Guappone et
al, 1998; Gibson et al, 1994; Shaw et al, 1996; Qian et al, 1998).  The carboxy terminus
of AFAP-110 modulates self-association and links AFAP-110 to both actin filaments and
cell membrane (Qian et al, 1998).   Therefore, AFAP-110 may have the ability to
modulate the interaction between Src and actin filaments.
Src transformation increases both AFAP-110’s tyrosine phosphorylation level as
well as serine/threonine phosphorylation level, and changes AFAP-110’s conformation
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(Kanner et al, 1991; Flynn et al, 1993; Qian et al, 1998).  Fusion proteins expressing the
Src SH3 domain (GST-SH3Src) were able to affinity absorb AFAP-110 from both chick
embryo fibroblast (CE) and Cos-1 cell lysates, but was unable to affinity absorb AFAP-
110 from Src transformed cell lysates (Flynn et al, 1993).  In addition, AFAP-110 exists
as a tetramer, trimer or monomer in vivo and multermerization is dependent on the
integrity of the carboxy terminus and the leucine zipper motif (Qian et al, 1998).  Src
transformation changes the profile of AFAP-110’s self-association.  Co-expression of
AFAP-110 with transformation competent form of Src (Src527F) reduces AFAP-110’s
self-association through the leucine zipper motif (Qian et al, 1998).  These data indicate
that Src transformation may induce a conformational change within AFAP-110.
AFAP-110 may have an intrinsic ability to modulate the integrity of actin
filaments through the leucine zipper motif.  Expression of the leucine zipper motif
deletion mutant of AFAP-110 (AFAP∆lzip) in Cos-1 cells repositions actin filaments into
rosette-like structures, similar to the phenotype of Src527F transformation (Qian et al,
1998). However, the Cos-1 cells are already SV40 transformed (Gluzman Y., 1981) and
their actin filaments are poorly organized, in addition AFAP∆lzip is expressed at extremely
high levels in Cos-1 cells.  Thus, it is possible that Cos-1 cells are particular susceptible
to the effects of AFAP∆lzip.  In this report, we tested a hypothesis to determine whether
AFAP-110 bound to actin filaments directly and whether the deletion of leucine zipper
motif altered the integrity of actin filaments and changed cell shape.
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Materials and Methods
Cell culture, in vivo expression and immunofluorescence localization.
Cos-1 cells were maintained and transfected as previously described (Guappone
et, 1996).  C3H10T1/2 cells were grown as previously described (Luttrell et al, 1988).
Immunofluorescence localization of transiently expressed AFAP-110 was accomplished
using mAb 4C3 followed by rabbit anti-mouse conjugated to rhodamine, as previously
described (Qian et al, 1998).  The mAb 4C3 preferentially recognizes the avian form of
AFAP-110 and not the endogenous, murine form of AFAP-110 found in C3H10T1/2
cells (Qian et al, 1999).  Both GFP and GFP-fusion proteins were detected as green
fluorescence in the targeted cells.  Actin filaments were imaged with phalloidin
conjugated to BODIPY 650/655 (Molecular Probes).  Images were analyzed in the WVU
Anatomy department Image Analysis Lab using a Zeiss confocal microscope LSM500
package and scanning different planes of the cell.  Images were collected in grayscale.
The pEGFP eukaryotic expression vector was used to express AFAP-110 or the
carboxy terminal 127 amino acids (amino acids 511-637), fused to green fluorescent
protein (GFP; Clontech). pGFP-AFAP-110 was created by shuttling AFAP-110 from
pGEX-6P-1-AFAP-110 to pEGFP-C3 vector using EcoRI(Clontech).  pGFP-Cterm was
created by shuttling AFAP-Cterm from pKS+/-AFAP-Cterm to pEGFP-C3 vector using
EcoRI.  pGFP-AFAP-110, pGFP-AFAP-cterm and pGFP were transiently transfected
into C3H10T1/2 cells using SuperFect Transfection Reagent (Qiangen).
Polypeptides and eukaryotic expression vectors.
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CT (The carboxy terminal 127 amino acids, amino acids 511-637), d42   (the
carboxy terminus 86 amino acids without coil/turn region, 553-637), d44 (the carboxy
terminal 84 amino acids without actin bindind domain, 511-593) and dlzip (the carboxy
terminus region without the leucine zipper motif, 511-553/593-637) were amplified by
PCR using primers that had BamH I and EcoR I restriction sites engineered into the ends.
The amplified cDNA product was digested with BamH I and EcoR I and subcloned into
pGex-6P-1 (Pharmacia). GST fusion proteins were generated from bacteria as previously
described (Flynn et al, 1993; Smith and Johnson, 1988).  The purified Glutathione
Sepharose Bead bound GST fusion proteins were digested by PreScissionTM Protease
(Pharmacia Biotech) in the cleavage buffer (50mM Tis, PH 7.0; 150mM NaCl; 1mM
EDTA; 1mM dithiothreitol) to isolate the polypeptides.  The polypeptides were separated
from the GST portion of the fusion protein and PreScissionTM Protease (which bound to
the Glutathione Sepharose Beads) by pelleting in a microfuge and isolating the
polypeptides from the supernatant.  The polypeptides were dialyzed two times against
actin buffer (5 mM Tris pH 8; 0.2 mM CaCl; 50 mM KCl; 2 mM MgCl2).
pCMV-1 constructs containing pp60527F and/or AFAP-110 were generated as
previously described and used for transient expression in Cos-1 cells .  Constructs
containing AFAP∆lzip and AFAP∆84 were generated as previously described (Qian et al,
1998). AFAP∆44 and AFAP∆22 were created by site-directed mutagenesis.  A stop codon
was introduced by changing the codon for Lys593 from AAA→TAA (for AFAP∆44) or
Lys616 from AAG→TAG (for AFAP∆22).  The newly created stop codon was confirmed
by DNA sequence analysis.  No second site mutations were identified within the 3' region
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of the construct that was subsequently subcloned into pCMV-AFAP-110, generating the
constructs called pCMV-AFAP∆44 or pCMV-AFAP∆22.
GFP fusion protein constructs
pGFP-AFAP-110 was created by shuttling AFAP-110 from pGEX-6P-1-AFAP-
110 to pEGFP-C3 vector using EcoRI(Clontech).  pGFP-Cterm was created by shuttling
AFAP-Cterm from pKS+/-AFAP-Cterm to pEGFP-C3 vector using EcoRI.  pGFP-
AFAP-110, pGFP-AFAP-cterm and pGFP were transiently transfected into C3H10T1/2
cells using SuperFect Transfection Reagent (Qiangen).
Protein characterization and analysis.
Protein concentrations and western blot analysis were performed as previously
described (Guappone and Flynn, 1997). Bound primary antibody was quantitated using
an HRP-conjugated secondary antibody followed by detection using chemiluminescence.
The monoclonal antibody 4C3 (Kanner et al, 1990) was used as previously described and
the polyvalent antibody (Ab) F1 was prepared as previously described(Flynn et al, 1993).
Isolation of immune complexes and western transfer were done as previously described
(Guappone et al, 1996).
Actin filament pelleting assay.
G-actin (Cytoskeleton Co.) was resuspended in general actin buffer (5 mM Tris
pH 8.0; 0.2 mM CaCl2).  The F-actin stock was prepared by adding actin polymerization
buffer (final concentration: 50 mM KCl; 2 mM MgCl2; 1 mM ATP) and incubated at
115
30oC for 30 min. The actin pelleting assays were performed by incubating 25µl C-
terminal or NINS polypeptides (20 µM) with 100ul F-actin (23 µM) at 30oC for 30min.
The reactions were centrifuged at 150,000  x  g for 1.5 hour at 4oC.  Both supernatants
and pellets were resolved by 14% SDS-PAGE gel.  Silver staining was used to visualize
the polypeptides that co-pelleted with actin filaments.
Results
There are two actin binding domains and a leucine zipper motif within carboxy
terminus of AFAP-110.
Earlier data showed that AFAP-110 colocalized with actin filaments in vivo and
the carboxy terminus of AFAP-110 is important for the colocalization (Qian et al, 1998).
Analysis of the carboxy terminal sequence of AFAP-110 revealed that there are two actin
binding domains between amino acids 593-637.  They have good homology with two
types of known actin binding domains identified in other actin filament-associated
proteins (Table 1).  The sequence defined by amino acids 601-615 demonstrates
homology with a consensus actin binding motif termed ABD1 (actin binding domain 1;
Taylor et al., 1998).  The sequence defined by amino acids 614-617 demonstrates
homology with an actin binding motif termed ABD3 (actin binding domain 3; Taylor et
al., 1998).   There is a leucine zipper motif defined by amino acids 553-595 (Qian et al,
1998).  It is a well-characterized protein binding domain existing in both transcription
factors as well as some cytoskeletal proteins.  One of its main functions is involved in
protein dimerization.
116
The actin binding domain region (amino acids 593-637) of AFAP-110 is necessary
for actin filaments binding in vivo
Based on the structural analysis of the carboxy terminus of AFAP-110, we
constructed different mutant variants of AFAP-110. The AFAP∆84, AFAP∆44, AFAP∆22,
and AFAP∆lzip constructs were generated by deletional mutagenesis and subcloned into
the mammalian expression vector pCMV-1 for transient expression in fibroblast cells, as
described in materials and methods (Figure 1).  AFAP∆84 lacks both actin binding
domains and the leucine zipper motif, AFAP∆44 lacks the two actin binding domains,
AFAP∆22 lacks actin binding doamin-3 and AFAF∆lzip lacks the leucine zipper motif.
Western blot analysis was used to qualitatively analyze the Mr of the transiently
expressed proteins in Cos-1 cells, as described earlier (Guappone et al., 1996). Protein
expression levels and Mr of these constructs are shown in Figure 1B.  The changes in Mr
seen with the deletion variants reflect the removal of coding sequence from AFAP-110.
The protein band seen at 85 kDa is a proteolytic breakdown product, as previously
demonstrated (Flynn et al., 1995; Qian et al, 1999).
Immunofluorescence localization of both overexpressed normal and mutant
variants of AFAP-110 constructs in C3H10T1/2 cells was used to determine whether the
actin binding domain region was important for co-localization with actin filaments.
C3H10T1/2 cells were chosen for these co-localization studies due to the ease in imaging
actin filaments in these cells, compared to Cos-1 cells. In addition, C3H10T1/2 cells are
murine derived fibroblasts, while the overexpressed AFAP-110 constructs are of avian
origin and an avian-specific monoclonal antibody, mAb 4C3, was used to selectively
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identify the overexpressed avian AFAP-110 constructs from endogenous AFAP-110
(Qian et al, 1999). Figure 2A-C demonstrate that overexpressed AFAP-110 co-localizes
well with actin filaments and the cell membrane.   However, deletion of the carboxy-
terminal 84 amino acids (amino acids 553-637) renders AFAP∆84 deficient in actin
filament colocalization (Figure 2D-F, black shaded arrow).  It is noteworthy that
AFAP∆84 was also unable to colocalize with the cell membrane (gray shaded arrow,
Figure 2D-F). AFAP∆44 did not efficiently colocalize with actin filaments (Figure 2G-I;
black shaded arrows), and was unable to colocalize with the cell membrane (Figure 2G-I;
gray shaded arrows). The positioning of AFAP∆44 was "grainy" and diffuse throughout
the cytoplasm, indicating that both actin bind domains are important for the
colocalization of AFAP-110 with actin filaments. Although AFAP∆22 was unable to align
as efficiently with actin filaments as AFAP-110, this deletion mutant did retain some
colocalization with actin filaments (Figure 2J-L).  These data indicate that amino acids
593-637, which contain both ABD-1 and ABD3 are required for efficient actin filament
colocalization, and ABD-1 may be centrally important for efficient actin filament binding
(gray shaded arrows).  Collectively, these data indicate that AFAP-110 has the potential
to directly interact with actin filaments through a putative actin binding motif ABD-1,
present between amino acids 601-617.
The carboxy terminus of AFAP-110 is sufficient to bind to actin filaments in vivo.
To determine whether the carboxy terminus of AFAP-110 itself can colocalize
with actin filaments, both AFAP-110 and the carboxy terminal region of AFAP-110 were
cloned into the pGFP vector to construct pGFP-cterm and pGFP-110, respectively.   Both
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pGFP-cterm and pGFP-110 were transiently transfected into Cos-1 cells and western blot
analysis was used to detect GFP-fusion proteins from cell lysates to confirm the
expression of GFP-fusion proteins (data not shown).  Immunofluorescence localization
was applied to determine the cellular localization of overexpressed GFP fusion proteins
in C3H10T1/2 cells.  The data show that when GFP was expressed alone, it is diffuse
throughout the cytoplasm and is unable to colocalize with either actin filaments or cell
membrane, indicating that GFP is not an actin binding protein and GFP fusion protein
system is applicable for immunofluorescence test (Figure 3D-F).  GFP-110 behaves like
AFAP-110 in C3H10T1/2 cells, it can be detected both on actin filaments and the cell
membrane (Figure 3A-C).  GFP-cterm is also located on both actin filaments and cell
membrane (Figure 3G-I). These data indicate that the carboxy terminus of AFAP-110
alone can colocalize with actin filaments and cell membrane.
The carboxy terminus of AFAP-110 directly binds to actin filaments in vitro and the
actin binding domain region (amino acids 593-637) is necessary for binding
An actin-filament pelleting assay was attempted to determine whether the carboxy
terminus of AFAP-110 had the potential to bind actin filaments, in vitro. Peptide d42,
representing the carboxy terminal 86 amino acids of AFAP-110, has both the leucine
zipper motif and actin binding domains.  D42 was generated using the pGex-6P vector,
affinity purified and proteolytically cleaved away from the GST fusion protein, as
described in materials and methods. As a negative control for actin binding, the 66 kDa
bovine serum albumen (BSA) protein was used. Recombinant AFAP-cterm and BSA
were quantitated by Coomasie staining and BCA protein analysis. The ability of the
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recombinant protein to bind polymerized non-muscle or muscle actin filaments was
accomplished by incubating them with polymerized actin filaments, followed by co-
pelleting at 150,000 x g, and then analyzing by Coomasie staining the ability of each
protein to co-pellet with actin filaments. In this experiment, peptide d42 co-pelleted with
both polymerized muscle and non-muscle actin filaments while BSA was unable to
efficiently co-pellet (Figure 4a). The estimated binding affinity of peptide d42 for non-
muscle actin filaments was 284 µM and for skeletal actin filaments was 191 µM. These
data indicate that AFAP-110 does contain the actin filament-binding domains, and can
co-pellet with actin filaments through these domains. It should be pointed out that under
the conditions used in these experiments, the skeletal muscle actin polymerized much
more efficiently than the non-muscle actin, hence, a majority of the resolved muscle actin
is in the pellet and a minority is in the supernatant. To further test whether the actin
binding domain region (the carboxy terminal 44 amino acids, 593-637) is necessary for
actin filament binding, the peptides CT, d44 and dlzip were generated and the actin co-
pelleting assay was performed.  CT contains the carboxy terminal 127 amino acids with
both the leucine zipper motif and actin binding domains (511-637), d42 contains the
carboxy terminus 86 amino acids without coil/turn region (553-637), d44 contains the
carboxy terminal 84 amino acids without actin bindind domain (511-593) and dlzip
contains the carboxy terminus region without the leucine zipper motif (511-553/593-637)
as mentioned in material and methods.  The data demonstrate neither BSA nor d44 were
able to co-pellet with actin filaments.  However, both CT and d42 pelleted with actin
filaments while dlzip pelleted with actin filaments less efficiently (Figure 4b).  The data
are consistent with our in vivo results.   Thus, AFAP-110 may bind actin filaments
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directly and the carboxy terminal 44 amino acids are necessary to modulate this
interaction.
Deletion of leucine zipper motif alters the integrity of actin filaments and
induces the formation of lamellipodia.
There are some functional implications for the direct binding of AFAP-110 to
actin filaments.  The leucine zipper motif and the two actin binding domains within the
carboxy terminus of AFAP-110 are predicted to form a long α-helix structure based on
secondary structure analysis (Qian et al, 1998).  The deletion variant of AFAP-110,
AFAP∆lzip, lacks amino acids 553-593 and has been demonstrated to reposition actin
filaments into rosette-like structures in transformed Cos-1 cells (Figure 5A-C) (Qian et
al., 1998).  However, no effect on morphology of these SV-40 transformed cells was
noted.  Here, non-transformed cell lines are chosen to test the effects of AFAP∆lzip on
actin filaments and cell morphology.  Immunofluorescence analysis revealed that
AFAP∆lzip also repositioned actin filaments cells into rosette-like structures in both
C3H10T1/2 and NIH 3T3 cells (Figure 5D-I).  In association with changes in actin
filament integrity a significant level of lamellipodia formation in both C3H10T1/2 and
NIH 3T3 cells transfected with AFAP∆lzip was noted and AFAP∆lzip colocalized with these
structures (gray shaded arrows, Figure 5A-I). The lamellipodia appeared as a bright
"ridge" at the cell membrane, rich in actin filaments and AFAP∆lzip was noted in these
structures in all transfected cells examined (gray shaded arrows, Figure 5A-I).  These
data indicate that leucine zipper may have an intrinsic ability to regulate AFAP-110's
ability to modulate the integrity of actin filaments and the formation of lamellipodia.
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Discussion
AFAP-110 has been demonstrated to colocalize with actin filaments and the cell
membrane in Cos-1 cells and chick embryo fibroblast (CE) cells (Flynn et al., 1993; Qian
et al., 1998).  In this report the sequences involved in facilitating interactions between
actin filaments and AFAP-110 were identified. Deletion of the carboxy terminal 84 or 44
amino acids were sufficient to prevent efficient co-localization with actin filaments,
based on immunofluorescence co-localization studies. However, removal of the carboxy
terminal 22 amino acids exerted a less drastic effect on colocalization with the cell
membrane and actin filaments while permitting some association with the cell membrane.
Thus, amino acids 593-615 are hypothesized to contain sequences that may be necessary
for actin filament co-localization, and amino acids 616-637 contain sequences that may
stabilize the actin filament binding.  Within this sequence, between amino acids 593-637,
two putative actin-binding motifs were identified based on a homology search: amino
acids 601-615 and amino acids 614-617.  Amino acids 601-615 demonstrate homology
with the known actin binding motifs of  Dystrophin, α-actinin, Spectrin, and others
(Matsudaira 1994; Taylor et al., 1998) and are referred to as Actin Binding Domain 1
(ABD1) in agreement with previously described nomenclature (Taylor et al., 1998).
ABD-1 usually has 26 conserved amino acids existing in many actin cross-link proteins
such as spectrin, dystrophin, fimbrin, and tensin.  In vitro studying found the polypeptide
representing this conserved sequence is sufficient to bind to actin filaments.  Amino acids
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614-617 (KLKK) demonstrate homology with the known actin-binding motifs of
Thymosin β4, Vilin and Vasp and are referred to as Actin Binding Domain 3 (ABD 3)
(Taylor et al., 1998).  ABD 3 has a consensus sequence of KLKK.   Deletion of both
putative actin binding motifs resulted in abrogation of actin-filament binding, in vivo, as
shown by images of AFAP∆44 or AFAP∆84.  These mutants also failed to colocalize with
the cell membrane.  AFAP∆22 retains the ABD1 motif (amino acids 601-615) but lacks
the second half of the ABD3 motif (amino acids 614-617).  This was accomplished by the
introduction of a stop codon in place of residue 616, causing protein translation to
prematurely end after amino acid Leu615.  When expressed in cells, AFAP∆22 is somewhat
deficient in actin colocalization; however, some actin colocalization was noted, especially
with the cell membrane. Therefore, it is likely that both ABD1 and ABD3, and possibly
additional sequences in the carboxy-terminus, are required for efficient colocalization of
the protein with actin filaments.  However, the presence of AFAP∆22 on the cell
membrane and with lamellipodia structures suggests a role for the first of the ABD1
motif (amino acids 601-615) in association of AFAP-110 with these structures.  It is
likely that membrane association reflects an interaction with the cortical actin matrix,
although this has not been demonstrated definitively. These data indicate that in vivo,
actin filament colocalization is modulated by sequences in the carboxy-terminal 44 amino
acids of AFAP-110.
The strong homology with known actin binding motifs indicated that AFAP-110
could associate with actin filaments directly.  Peptides representative of the carboxy
terminal 86 amino acids of AFAP-110 were able to co-precipitate with polymerized non-
muscle actin filaments, in vitro. Similarly, peptides CT and d42 were able to co-pellet
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with polymerized skeletal muscle actin filaments, indicating an ability to associate with
either non-muscle or skeletal muscle actin filaments, in vitro.  Peptide d44 was unable to
co-pellet with actin filaments, indicating the actin binding domain region is necessary for
actin binding activity in vitro.   The data are totally consistent with the in vivo results that
demonstrate AFAP∆44 is deficient for colocalizing with actin filaments, indicating that the
actin binding domain region is necessary for actin filament binding.   In vivo data
demonstrate the carboxy terminus of AFAP-110 colocalized with both actin filaments
and the cell membrane when it was expressed alone. The data are consistent with the
results that both AFAP∆84 and AFAP∆44 are unable to colocalize with either actin
filaments, cell membrane or lamellipodia structures.   Taken together, the data imply the
carboxy terminus of AFAP-110 may be both necessary and sufficient to bind actin
filaments directly in vivo and the last 44 amino acids, where the actin binding domains
are located, are critical. Earlier data showed that AFAP-110 has the ability to
multimerize, ranging from monomers to tetramer in vivo.  We predicted that AFAP-110
may cross-link and bundle actin filaments through its ability to multimerize in vivo.
It was previously reported that a deletion in the carboxy terminus of AFAP-110
(AFAP∆lzip) was sufficient to reposition actin filament structures in Cos-1 cells (Qian et
al., 1998).  However, the Cos-1 cells are already transformed by SV-40 virus, their actin
filaments are not well organized and relatively thin and AFAP∆lzip are extremely
overexpressed in the Cos-1 cells.  Those properties may have made Cos-1 cells more
susceptible to AFAP∆lzip.  Thus, both C3H10T1/2 and NIH3T3 cells were used to test the
effects of AFAP∆lzip on actin filaments.  Neither C3H10T1/2 nor  NIH3T3 cells are
oncogenically transformed cells and their actin filaments are well organized.  Expression
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of AFAP∆lzip in both C3H10T1/2 cells and NIH3T3 cells also repositions the actin
filament into rosette like structure, similar to what was seen in cells expressing Src527F.
The AFAP∆lzip transfected cells also demonstrated changes in cell morphology
characterized by the increased levels of lamellipodia formation, unlike the cells
transfected with wild-type AFAP-110 or any of the other deletion variants used in this
study. The lamellipodia is full of meshwork of actin filaments that are in constant
rearrangements and Src527F transformation can induce the formation of lamellipodia
within minutes (Thomas SM and Brugge JS, 1997).  These data indicate that AFAP-110
may have an intrinsic capability to alter actin filament integrity through its leucine zipper
motif, in vivo.
Expression of AFAP∆lzip in Cos-1 cells, followed by separation by gel filtration
demonstrate that AFAP∆lzip is detected only in the dimeric form and not in the tetrameric
or trimeric forms as AFAP-110 is (Qian and Flynn, unpublished data).  Therefore, the
leucine zipper motif may play a functional role in both regulating the ability of AFAP-
110 to multimerize and the capability of AFAP-110 to alter actin filament integrity.
These two functions could also be linked.  In addition, Src transformation alters actin
filaments and induces the formation of lamellipodia, similar to the phenotype of the
expression of AFAP∆lzip , and coexpreesion of AFAP-110 with Src527F reduces the
multimerization of AFAP-110 into dimeric form, which could result from changes in
conformation of the leucine zipper motif.  Those data indicate that Src transformation
may induce a conformational change in the leucine zipper motif and thus enable AFAP-
110 to modulate the integrity of actin filaments.
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Tables
Homology to ABD-1
AFAP-110 (avian, 601-615) V N A G R K T Q V I L E D K L
Dystrophin (human, 92-106) V N I G S T D I V D G N H K L
Dystrophin (avian, 96-110) V N I G S S D I V D G N H K L
α-Actnin (dicty, 101-115) V G I G A E E L V D K N L K M
α-actinin (avian, 120-134) V S I G A E E L V D G N A K M
Spectrin (drosophila,127-141) E N I G S H K I V D G N A S L
Spectrin (human, 131-145) E N M G S H D I V D G N H R L
ABP-120 (dicty, 90-104) V G I G A E D I V D S Q L K L
ABP V S I D S D A I V D G N L K L
Filamin (122-136) V S I D S K A I V D G N L K L
Tensin (avian, 372-385) E N G P S V S V - D Y N T S D
Fimbrin (avian, 211-225) V N I G S Q D L Q E G K P H L
T-plastin (human, 209-223) V N I G A E D L R A G K P H L
Homology to ABD-3
AFAP-110 (614-617) K L K K
Thymosin β4 (17-20) K L K K
Villin (818-821) N L K K
Vasp (234-237) K L R K
Table 1.  Alignment of the carboxy terminus of AFAP-110 with known actin
binding motifs termed actin binding domain 1 (ABD1) and actin binding domain 3
(ABD3). Species from which these proteins were cloned are shown in parentheses as well
as the amino acids. Shaded areas indicate regions of identity or homology.
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Figures and Figure Legends
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Figure 1.  (A) The AFAP-110, AFAP∆84, and AFAP∆lzip constructs were generated
as previously described [26].  AFAP∆44 was generated by engineering a stop codon in
place of Lys593 and AFAP∆22 was generated by engineering a stop codon in place of
Lys616, thus removing the carboxy-terminal 44 or 22 amino acids from the AFAP-110
open reading frame. (B) Expression of AFAP-110 constructs in Cos-1 cells.  Each AFAP-
110 construct was transiently expressed in Cos-1 cells and protein expression levels
measured from cell lysates 66 hours post transfection.  Twenty-five µg of cell lysate was
resolved by 8% SDS-PAGE, transferred to PVDF by western transfer and probed with
mAb 4C3, followed by quantitation with sheep anti-mouse conjugated to HRP and
chemiluminescence.
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Figure 2.  Immunofluorescence labeling patterns of AFAP-110 deletion constructs
in C3H10T1/2 cells.  C3H10T1/2 cells were transiently transfected and probed for
AFAP-110 overexpression as described in materials and methods. To differentiate
transfected avian AFAP-110 mutants from endogenous AFAP-110, the avian specific
mAb 4C3 antibody was used.  Panels A, D, G and J show emission of rhodamine-
conjugated rabbit anti-mouse, which recognizes the monoclonal 4C3 antibody,
demonstrating the localization of transiently over-expressed AFAP-110 in C3H10T1/2
cells.  Panels B, E, H and K show emission of BODIPY 650/655-conjugated phalloidin,
which demonstrates the sub-cellular localization of actin. Panels C, F, I and L represent a
composite emission pattern for AFAP-110 (and deletion variants) with actin filaments.
Yellow indicates co-localization. Cells transfected with AFAP-110 and mutants are as
follows: Panels A-C, AFAP-110; Panels D-F, AFAP∆84; Panels G-I,  AFAP∆44; and
Panels J-L, AFAP∆22.  Gray shaded arrows indicate membrane.  Black shaded arrows
indicate actin filaments.
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Figure 3. Immunofluorescence labeling patterns of both GFP and GFP-fusion
protein in C3H10T1/2 cells.  C3H10T1/2 cells were transiently transfected and probed
for both GFP and GFP fusion protein overexpression as described. Panel A, D, and G
show emission of green fluorescence (which were false colored red), demonstrating the
localization of transiently over-expressed both GFP and GFP fusion proteins.  Panel B, E,
and H show emission of BIODIPY 650/655-conjugated phalloidin , which demonstrates
the sub-cellular localization of actin filaments, which were false colored green.Panel C,
F, and I represent a composite emission patter for GFP fusion proteins with actin
filaments.  Yellow indicates co-localization.  The order of cell transfection is follows:
Panel A-C, GFP-AFAP-110; Panel D-F, GFP; Panel G-I, GFP-Cterminal.
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Figure 4. Actin filament co-pelleting assay. The purified carboxy terminal 86
amino acids (Cterminal)  co-pelleted with  both purified muscle and non-muscle actin
filaments in vitro.  Silver stain demonstrates the co-pellets of the C-terminal or BSA
polypeptides with the actin filaments pellet (Pellet) or supernatant (Sup.).  MW markers
are noted. BSA has a Mr of 66 kDa while the C-terminal polypeptide has a Mr of 10 kDa.
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Figure 5.  AFAP-110 binds to actin filaments in vitro via amino acids 594-637.
(A) polypeptides representative of amino acids 511-637 (the carboxy terminus; CT),
amino acids 552-637 (d42, which lacks the coil/turn region shown in Figure 1); amino
acids 511-593 (d44, which lacks the actin binding domains), or amino acids 511-552/593-
637 (dlzip, which lacks the leucine zipper motif) were generated as described in materials
and methods.  (B) The polypeptides were mixed with polymerized actin filaments and
BSA and pelleted, followed by resolution of the S and P fractions using 12% SDS-PAGE
and silver staining.  The S fraction is the supernatant fraction and contains proteins not
bound to actin filaments while the P fraction contains the pelleted actin filaments.  The
Mr of the CT, dlzip, d44 and d42 polypeptides are noted and were confirmed by running a
separate gel resolving the purified polypeptides and silver stain.
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Figure 6. Immunofluorescence labeling patterns of AFAP∆lzip deletion construct in
Cos-1 cells, C3H10T1/2 cells and NIH 3T3 cells.  The cells were transiently transfected
and probed for AFAP∆lzip  overexpression as described in materials and methods.  To
differentiate transfected avian AFAP∆lzip  from endogenous AFAP-110, the avian specific
mAB 4C3 antibody was used.  Panels A, D, and G show emission of rhodamine-
conjugated rabbit anti-mouse, which recognizes the monoclonal 4C3 antibody,
demonstrating the localization of transiently over-expressed AFAP∆lzip  in the cells.
Panels B, E, and H show emission of BODIPY 650/655-conjugated phalloidin, which
demonstrates the sub-cellular localization of actin filaments.  Panels C, F, and I represent
a composite emission pattern for AFAP∆lzip with actin filaments.  Yellow indicates co-
localization.  The order of cells is follows: Panels A-C, Cos-1 cells; Panels D-F,
C3H10T1/2 cells; Panels G-I, NIH 3T3 cells.
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CHAPTER 5
General Discussion
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Src is one of the earliest identified oncogenes (Brugge and Erikson, 1977).  Src
transformation changes cell morphology, which is linked to the changes of actin filament
based cytoskeleton.   The mechanisms by which Src affects the integrity of actin
filaments are unknown.  One candidate protein that may serve as a model system to study
the effects of Src upon the integrity of actin filaments is AFAP-110.  AFAP-110 is both
an actin filament binding protein and a Src substrate.  Its’ domain structure indicates that
AFAP-110 may facilitate the interactions between Src (and other signal proteins) with
actin filaments.  Ultimately, this may lead to a change in cell shape.
There are three isoforms of AFAP-110: AFAP-110, AFAP-120 and AFAP-82.
AFAP-120 encodes an additional 86 amino acids compared to AFAP-110, which are
inserted just amino terminal to the carboxy terminal 127 amino acids of AFAP-110.  The
carboxy terminus of AFAP-120 is identical to that of AFAP-110.  AFAP-82 conserves all
the protein motifs of AFAP-110, except it lacks the carboxy terminus.  Those data
indicate that the carboxy terminus of AFAP-110 may be important for the function of
AFAP-110.  The overall goal of my dissertation was to determine the functional roles of
the carboxy terminus of AFAP-110.
In chapter two, two monoclonal antibodies to AFAP-110 were mapped.  Mab 4C3
recognizes an epitope that is part of SH3 binding motif.  Importantly, Mab 4C3 is unable
to efficiently react with mammalian homologous AFAP-110 due to one amino acid
difference of Mab 4C3’s epitope between avian AFAP-110 and mammalian AFAP-110.
This property is unique for Mab 4C3, as we can use its epitope as an internal epitope-tag
to localize avian AFAP-110 expressed in mammalian cells.  Mab anti-AFAP-110
recognizes an epitope, including and around the 5th leucine zipper motif heptad repeat
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within the carboxy terminus of AFAP-110.  The leucine zipper motif may mediate the
function of AFAP-110.  Thus, mab anti-AFAP-110 is a useful monoclonal antibody to
study the function of AFAP-110.
There is an 82 kDa proteolytic breakdown product of AFAP-110 in both
endogenous and overexpressed AFAP-110.  This 82 kDa band can be detected by both F1
and 4C3 antibodies, but is not detected by Mab anti-AFAP-110,  and its Mr is slightly
decreased compared to that of AFAP∆84, indicating this proteolytic breakdown product
lacks carboxy terminal sequence.  AFAP-110 associates with actin filaments through the
carboxy terminus.  This implies that removal of the carboxy terminus by proteolysis may
provide a mechanism by which AFAP-1100/actin filament interactions could be
regulated.  Similar results have been identified with other signaling proteins (Yao et al,
1993; Shuster et al, 1995).   This indicates that the carboxy terminus of AFAP-110 may
be important for the function of AFAP-110.
The very carboxy terminal end 84 amino acids form a long α helical structure and
the leucine zipper motif is located at the N-terminus of this long α helix.  The existence
of leucine zipper motif implies AFAP-110 may have the ability to self-association.  In
chapter 3, both the affinity absorption data and FPLC data demonstrate AFAP-110 does
have the ability to self-associate in vivo and the carboxy terminal α helix region may
mediate this self-association.  AFAP-110 is an actin binding protein, the ability to self-
associate indicates that AFAP-110 may behave as an actin bundling protein, facilitating
actin filament bundling in vivo.   Future experiments will be needed to address this issue.
We still don’t know the mechanism by which AFAP-110 self-associates in vivo.  Our
data indicate that the self-association may not be mediated by the classic leucine zipper
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interactions. It may be mediated by an interaction between leucine zipper motif and its
upper stream region.  Identification of the mechanism (s) by which AFAP-110 associate
(s) with each other in vivo is important.  As Src transformation changes the profile of
AFAP-110’s self-association through the leucine zipper motif in vivo, and the changes of
self-association pattern in vivo may provide some mechanisms as for how AFAP-110
mediates the effects of Src upon actin filaments.  In the future, we will detect the leucine
zipper motif binding partner in the amino terminus and determine whether the deletion of
this binding partner will have the same effects upon the cells as AFAP∆lzip.
In both chapter 3 and 4, we demonstrate that the last 44 amino acids (593-637) of
the carboxy terminus are necessary for actin filament association both in vivo and in
vitro, and the carboxy terminus of AFAP-110 is sufficient to bind actin filaments both in
vivo and vitro.  In vitro actin filament co-pelleting assays indicate AFAP-110 may bind to
actin filaments directly.   Analysis of the last 44 amino acids revealed two homologous
actin binding domains. The structural analysis data are consistent with early research data
and indicate a mechanism by which AFAP-110 directly associates with actin filament.
To further test the importance of the two actin binding domains for AFAP-110’s cellular
localization, we could do point mutations to mutate crucial amino acids within the two
actin binding domains, and transfect mammalian cells to see whether these mutated
AFAP-110s co-localize with actin filaments or not. We might put these point mutations
into AFAP∆lzip to see whether the mutants could abrogate the effects of AFAP∆lzip on actin
filaments.  We might further challenge these transfected cells with Src527F to test whether
the mutation within actin binding domains will change the effects of Src527F on actin
filaments. The mutant(s) that could block changes in actin filaments will be served as the
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dominant negative AFAP-110 for future research.  Therefore, these experiments might
tell us the importance of the association of AFAP-110 with actin filaments in mediating
the effects of Src527F transformation upon actin filaments.
The leucine zipper motif may have a significant role in regulating AFAP-110’s
ability to modulate the integrity of actin filaments. Transient transfection of cells with
AFAP∆lzip disrupts the integrity of actin filaments, and redistrubutes actin filaments into
rosette-like structure similar as the phenotype of Src527F transformation.  We also mutated
the third leucine residue into a proline within the leucine zipper motif (AFAPL581P ).   The
AFAPL581P was transfected into the cells and the similar phenotypic changes were
observed as with AFAP∆lzip (data is not shown).  The data imply that Src527F may affect
the integrity of actin filaments by changing the conformation at the leucine zipper motif.
It also suggests that AFAP-110 may have intrinsic ability to modulate the integrity of
actin filaments, which is regulated by the leucine zipper motif.  One question raised is
how does the leucine zipper motif regulate AFAP-110’s ability to modulate the effects of
Src527F upon actin filaments.  There are two possible mechanisms by which the leucine
zipper motif may regulate AFAP-110 to modulate the integrity of actin filaments.  The
first possible mechanism is that protein interactions, mediated by the leucine zipper
motif, are changed upon either deletion and point mutation of the leucine zipper motif or
Src527F transformation, which enables AFAP-110 to affect the integrity of actin filaments.
The second mechanism is that the structure of leucine zipper motif itself, which is part of
the long α-helix at the carboxy terminus, is changed upon either mutation within the
leucine zipper motif or transformation by Src527F.    Dr. C. Vinson indicated to us that the
point mutation at leucine 581 to proline placed a kink structure within α-helix and
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disrupted the structural integrity of leucine zipper motif.  Src527F transformation could
have the same effects on leucine zipper motifs as AFAPL581P does.  Src527F can activate
serine/threonine phosphorylation in vivo (Pawsons and Weber, 1989) and
serine/threonine phosphorylation may disrupt the structural integrity of leucine zipper
motif.  Protein lamin is an example.  It has a leucine zipper motif involved in
dimerization.  The phosphorylation of serine/threonine residues near the leucine zipper
motif creates a perturbation within the leucine zipper motif, which disables lamin to form
homodimer (Heald and Mckeon, 1990). It is possible that phosphorylation of Ser/Thr
residues near the leucine zipper motif of AFAP-110 may place a perturbation or a kink
structure within the leucine zipper motif, which disrupts the structural integrity of α-
helix, similar to the effects of deletion or point mutation of the leucine zipper motif.
Currently, these two possible mechanisms are being tested in this lab.  We
screened the Gene-bank database and found cFos had a homologous leucine zipper motif
compared to that of AFAP-110. This homologous leucine zipper motif was cloned into
AFAP-110∆lzip to create a chimeric AFAPcfos/lzip construct.  The chimeric AFAPcfos/lzip was
predicted to restore the integrity of carboxy terminal α-helix structure, but would mediate
different protein interactions.  The chimeric protein (AFAP-cfos/lzip) was transfected
into C3H10T1/2 cells.  The immunofluroscence data showed the integrity of actin
filaments was restored, and AFAP-cfos/lzip was colocalized with actin filaments (data
not shown).  The results indicate the structural integrity of leucine zipper motif may be
essential for modulating the integrity of actin filaments and protein interactions may be
less important.  Further experiments will be needed to verify the importance of structural
integrity of leucine zipper motif by substituting the 3rd leucine of the chimeric heptad
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repeats with Proline (similar as AFAPL581P).  This mutated chimeric AFAP-cfos/lzip will
be transfected into mammalian cells to see whether this mutant will also affect the
integrity of actin filaments same as AFAPL581P does.  Additional experiments are needed
to test whether cfos’ leucine zipper motif is functionally active i.e. whether this leucine
zipper motif permits affinity absorption of AFAP-110, in vitro.
The mechanisms by which AFAP-110 affects the integrity of actin filaments are
still unclear. Our data strongly suggest that AFAP-110 may have an intrinsic ability to
alter actin filaments directly and the region that mediates this activity may be located to
carboxy terminal 44 amino acids. To test this hypothesis, we performed an actin filament
viscosity assay (MacLean-Fletcher and Pollard, 1980).  We mixed purified GST-cterm,
GST-cterm∆lzip, GST-cterm∆84 and GST fusion proteins with G-actin, and polymerized G-
actin to F-actin in the presence of these fusion proteins. The fusion protein/actin mixtures
were applied into the capillary tubes and the time for a steel ball to fall in the tubes was
measured.  The theory of this experiment is the polymerized actin filaments have high
viscosity while proteins that alter the integrity of actin filaments decrease the viscosity.
The relative viscosity can be measured by calculating the falling speed of steel balls.  Our
unpublished data showed that only GST-cterm∆lzip, among the four fusion proteins,
decreased the viscosity of actin filaments, which indicates that GST-cterm∆lzip may have
an intrinsic ability to directly alter the integrity of actin filaments and the leucine zipper
motif may play a regulatory role as GST-cterm has no effect on the viscosity (figure 1).
The sequence region that has the ability to directly alter the integrity of actin filaments
may exist within last 44 amino acids of the carboxy terminus, as GST-cterm ∆84 is unable
to decrease the viscosity.  There are four possible ways for proteins to inhibit the
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polymerization of actin filaments i.e. decrease the viscosity of actin filaments here.  They
include (a) sequestering monomeric actin, (b) severing, (c) capping or (d) destabilizing
the filaments.  Further experiments are needed to address these mechanisms.
The novel data in this thesis are that deletion of the leucine zipper motif within AFAP-
110 can induce the formation of lamellipodia and changes in cell shape.  The data
indicate that AFAP-110 has an intrinsic ability to remodel  actin filaments, regulate the
formation of lamellipodia and the leucine zipper motif may play a regulatory role, which
are consistent with our earlier data that AFAP-110 has the intrinsic ability to alter the
integrity of actin filaments. Src transformation induces the formation of lamellipodia
within minutes, which is concomitant with the increase of cell migration (Thomas and
Brugge, 1997).  This implies that AFAP-110 may have the ability to mediate the effects
of Src527F upon actin filaments, through the leucine zipper motif.  As I discussed in
chapter one, the lamellipodia is the cell membrane protrusion at the leading edge of
migrating cells, and is full of actin filament meshwork. The actin filaments within
lamellipodia are highly dynamic and actively remodel (Welch et al, 1997).  The
formation of lamellipodia correlates with cell migration (Bearer et al, 1993).  Therefore,
our data indicate that AFAP-110 may effect cell motility. Modified Boyden chamber
assays indicated that AFAP∆lzip expression increases cell motility  4-times above wild
type AFAP-110 expression (Baisden and Flynn, unpublished data).
In chapter 3, the data indicate that Src527F can affect AFAP-110’s self-association,
cell localization and actin filament integrity, and these effects may be achieved through
regulating the carboxy terminal interactions of AFAP-110.  We still don’t know whether
Src527F interacts with AFAP-110 directly or indirectly.  Our lab’s earlier data showed
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Src527F could bind to AFAP-110 directly, in vitro.  But in vivo experiments showed that
Src527F could still disrupt actin filaments when it was coexpressed with mutant AFAP-110
that was deficient for binding to Src527F(Guappone and Flynn, unpublished data).  This in
vivo data indicate the direct interaction between Src527F and AFAP-110 may not be
necessary for the effects of Src527F upon actin filaments.  In chapter 3, we also found that
the disruption of affinity absorption of AFAP-110 by GST-cterm is independent of
tyrosine phosphorylation by Src527F.  Therefore, it is possible that AFAP-110 could
indirectly mediate the effects of Src527F upon actin filaments through serine/threonine
phosphorylation.   Indeed, Kanner (1991) found Src527F could increase the
serine/threonine phosphorylation level of AFAP-110.  One candidate protein that could
mediate the effects of Src527F upon AFAP-110’s serine/threonine phosphorylation is PKC
or Rho-GTPase protein Rac.  The active Rac kinase, which is one of main stimulators
that induce the formation of lamellipodia and membrane ruffles (Tapon and Hall, 1997).
We hypothesize that Src527F and other kinases may activate Ras, and the activated Ras
may activate Rac.  The activated Rac may interact with AFAP-110, which alters the
integrity of actin filaments and remodulates actin filaments to induce the formation of
lamellipodia directly.  Currently, our lab is actively doing research to address this issue.
Indeed, Baisden and Flynn demonstrated that PKC will bind to AFAP-110 (unpublished
data).
 In summary, we demonstrated in this thesis that 1) Mab anti-AFAP-110
recognizes an epitope within the carboxy terminal region of AFAP-110; 2) Mab 4C3
recognizes an epitope within SH3 binding motif of AFAP-110, which is avian specific; 3)
the carboxy terminus of AFAP-110 has a leucine zipper motif and two actin binding
155
domains; 4) AFAP-110 may have the ability to self-association in vivo and the self-
association may be mediated through the carboxy terminus of AFAP-110; 5) AFAP-110
can bind to actin filaments directly through its carboxy terminal 44 amino acids; 6)
AFAP-110 has the intrinsic ability to alter the integrity of actin filaments and remodulate
actin filaments to induce formation of lamellipodia and changes of cell shape, which are
regulated through its leucine zipper motif; 7) Src527F has the ability to influence AFAP-
110’s self-association, cell localization and actin filament integrity through the leucine
zipper motif.
Here is our working model as for how AFAP-110 affects the integrity of actin
filaments.  AFAP-110 binds to actin filaments directly through the carboxy terminal 44
amino acids.  Src527F and other cell signals interact with AFAP-110 and change the
integrity of AFAP-110’s leucine zipper motif.  The altered leucine zipper motif enables
AFAP-110 to rearrange and remodel actin filaments to induce the formation of
lamellipodia and membrane ruffle through the carboxy terminal 44 amino acids.
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Actin filament viscosity assay
Actin was prepared from rabbit fast skeletal muscle acetone powder (Maclean-
Fletcher and Pollard, 1980).  Crude G-actin and filtered with Sephacryl S-300 in G-buffer
(2 mM imidazole, pH 7.5, 0.2 mM ATP, 0.2 mM CaCl2, 0.5 mM DTT, 3 mM NaN3).
Apparent low shear viscosity was measured by falling ball viscometry (Maclean-Fletcher
and Pollard, 1980).  Samples of 180 µl were prepared with G-buffer containing 10 µM G-
actin and AFAP-110 fusion proteins (GST-∆lzip and GST-∆84).  Polymerization was
induced with the addition of 20 µl of a solution containing 500 mM KCl, 10 mM MgCl2,
10 mM EGTA, 100 mM imidazole, pH 7.5.  The mixed sample was immediately drawn
into a cappilary tube (100 µl).   The tube was incubated vertically at least 2 hr at 25°C
before measuring the time for a steel ball to fall 8 cm in the tube.
158
159
Figure 1. Fusion proteins expressing the carboxy terminus of AFAP∆lzip can reduce actin
filament viscosity, in vitro.  Polymerization of actin filaments into a viscous solution was
performed in the presence of different concentrations of purified GST-∆lzip or GST-∆84.
Relative viscosity was plotted as described in materials and methods.  Panels A and B
represent two independent experiments.
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